<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:wrap="http://wrap.com/20260331"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="wrap-20260331.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
        </entity>
        <period>
            <instant>2026-05-11</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wrap:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wrap:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wrap:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wrap:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wrap:ExtendedWarrantiesAndServicesVRAndTrainingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wrap:ExtendedWarrantiesAndServicesVRAndTrainingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wrap:BolaWrapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wrap:WRAPReadyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wrap:IntrensicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:TechnologyServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wrap:TrainingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wrap:WrapTacticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wrap:CustomerDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wrap:ExtendedWarrantiesAndServicesVRAndTrainingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wrap:CustomerDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wrap:ExtendedWarrantiesAndServicesVRAndTrainingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wrap:CustomerDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wrap:ProductionAndLabEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wrap:ProductionAndLabEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wrap:ToolingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wrap:ToolingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">wrap:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-29</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">wrap:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-29</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wrap:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-24</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-24</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wrap:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-18</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wrap:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-18</instant>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wrap:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wrap:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wrap:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-03</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wrap:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-03</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wrap:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-03</instant>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wrap:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-03</instant>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-03</startDate>
            <endDate>2023-07-03</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-18</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-18</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wrap:TwoThousandSeventeenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wrap:TwoThousandSeventeenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wrap:ServicebasedOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wrap:TwoThousandSeventeenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wrap:PerformanceBasedOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wrap:TwoThousandSeventeenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wrap:PerformanceBasedOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wrap:TwoThousandSeventeenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wrap:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wrap:PerformanceBasedOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wrap:TwoThousandSeventeenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-30</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-31</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wrap:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-18</startDate>
            <endDate>2025-08-18</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:V4GlobalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:V4GlobalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:V4GlobalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:ContinuumVenturesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:ContinuumVenturesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:ContinuumVenturesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:SavboInvestmentsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:SavboInvestmentsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:SavboInvestmentsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:V4GlobalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:February2026CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:V4GlobalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:V4GlobalLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wrap:SavboInvestmentsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:February2026CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:SavboInvestmentsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:SavboInvestmentsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:JuggernautManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">wrap:February2026CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:JuggernautManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wrap:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wrap:JuggernautManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wrap:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wrap:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wrap:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wrap:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wrap:DistributorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wrap:DistributorTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wrap:DistributorThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wrap:DistributorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">wrap:DistributorTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wrap:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wrap:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Subsidiary">
        <measure>wrap:Subsidiary</measure>
    </unit>
    <unit id="Segment">
        <measure>wrap:Segment</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Customers">
        <measure>wrap:Customers</measure>
    </unit>
    <unit id="Distributors">
        <measure>wrap:Distributors</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-5163">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c0" id="ixv-28">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-33">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-5164">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-37">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-44">001-38750</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-51">Wrap Technologies, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-60">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-66">98-0551945</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-5165">3350 Virginia Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0" id="ixv-5166">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-87">Miami</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-5167">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-5168">33133</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-5169">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-5170">583-2652</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0" id="ixv-116">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0" id="ixv-122">WRAP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0" id="ixv-129">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-133">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-137">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-154">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-162">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-171">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c0" id="ixv-178">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c1"
      decimals="INF"
      id="ixv-5171"
      unitRef="shares">55738250</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c2" decimals="-3" id="ixv-5172" unitRef="usd">7264000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="-3" id="ixv-5173" unitRef="usd">3468000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c2" decimals="-3" id="ixv-5174" unitRef="usd">1991000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c3" decimals="-3" id="ixv-5175" unitRef="usd">2787000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c2" decimals="-3" id="ixv-5176" unitRef="usd">4645000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c3" decimals="-3" id="ixv-5177" unitRef="usd">4971000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c2" decimals="-3" id="ixv-5178" unitRef="usd">574000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c3" decimals="-3" id="ixv-5179" unitRef="usd">194000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c2" decimals="-3" id="ixv-5180" unitRef="usd">14474000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="-3" id="ixv-5181" unitRef="usd">11420000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="-3" id="ixv-5182" unitRef="usd">105000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-3" id="ixv-5183" unitRef="usd">123000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c2" decimals="-3" id="ixv-5184" unitRef="usd">447000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c3" decimals="-3" id="ixv-5185" unitRef="usd">2175000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c2" decimals="-3" id="ixv-5186" unitRef="usd">1592000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c3" decimals="-3" id="ixv-5187" unitRef="usd">1572000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="c2" decimals="-3" id="ixv-5188" unitRef="usd">104000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c3" decimals="-3" id="ixv-5189" unitRef="usd">128000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c2" decimals="-3" id="ixv-5190" unitRef="usd">16722000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c3" decimals="-3" id="ixv-5191" unitRef="usd">15418000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c2" decimals="-3" id="ixv-5192" unitRef="usd">787000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c3" decimals="-3" id="ixv-5193" unitRef="usd">620000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-5194" unitRef="usd">531000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c3" decimals="-3" id="ixv-5195" unitRef="usd">407000</us-gaap:AccruedLiabilitiesCurrent>
    <wrap:CurrentLiabilitiesCustomerDeposits contextRef="c2" decimals="-3" id="ixv-5196" unitRef="usd">51000</wrap:CurrentLiabilitiesCustomerDeposits>
    <wrap:CurrentLiabilitiesCustomerDeposits contextRef="c3" decimals="-3" id="ixv-5197" unitRef="usd">62000</wrap:CurrentLiabilitiesCustomerDeposits>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c2" decimals="-3" id="ixv-5198" unitRef="usd">449000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c3" decimals="-3" id="ixv-5199" unitRef="usd">408000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c2" decimals="-3" id="ixv-5200" unitRef="usd">90000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c3" decimals="-3" id="ixv-5201" unitRef="usd">320000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-5202" unitRef="usd">1908000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="-3" id="ixv-5203" unitRef="usd">1817000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c2" decimals="-3" id="ixv-5204" unitRef="usd">11000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c3" decimals="-3" id="ixv-5205" unitRef="usd">14000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c2" decimals="-3" id="ixv-5206" unitRef="usd">369000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c3" decimals="-3" id="ixv-5207" unitRef="usd">2097000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c2" decimals="-3" id="ixv-5208" unitRef="usd">380000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c3" decimals="-3" id="ixv-5209" unitRef="usd">2111000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c2" decimals="-3" id="ixv-5210" unitRef="usd">2288000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c3" decimals="-3" id="ixv-5211" unitRef="usd">3928000</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c2"
      decimals="INF"
      id="ixv-5212"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c3"
      decimals="INF"
      id="ixv-5213"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c2"
      decimals="INF"
      id="ixv-5214"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c3"
      decimals="INF"
      id="ixv-5215"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c2"
      decimals="INF"
      id="ixv-5216"
      unitRef="shares">11707</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ixv-5217"
      unitRef="shares">11707</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c3"
      decimals="INF"
      id="ixv-5218"
      unitRef="shares">12707</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c3"
      decimals="INF"
      id="ixv-5219"
      unitRef="shares">12707</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c2" decimals="-3" id="ixv-5220" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c3" decimals="-3" id="ixv-5221" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c2"
      decimals="INF"
      id="ixv-5222"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c3"
      decimals="INF"
      id="ixv-5223"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c2"
      decimals="INF"
      id="ixv-5224"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c3"
      decimals="INF"
      id="ixv-5225"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="c2"
      decimals="INF"
      id="ixv-5226"
      unitRef="shares">55506692</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ixv-5227"
      unitRef="shares">55506692</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c3"
      decimals="INF"
      id="ixv-5228"
      unitRef="shares">51733217</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c3"
      decimals="INF"
      id="ixv-5229"
      unitRef="shares">51733217</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c2" decimals="-3" id="ixv-5230" unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c3" decimals="-3" id="ixv-5231" unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c4"
      decimals="INF"
      id="ixv-5232"
      unitRef="shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c5"
      decimals="INF"
      id="ixv-5233"
      unitRef="shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c4"
      decimals="INF"
      id="ixv-5234"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c5"
      decimals="INF"
      id="ixv-5235"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c4"
      decimals="INF"
      id="ixv-5236"
      unitRef="shares">8107</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ixv-5237"
      unitRef="shares">8107</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c5"
      decimals="INF"
      id="ixv-5238"
      unitRef="shares">8207</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ixv-5239"
      unitRef="shares">8207</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c4" decimals="-3" id="ixv-5240" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c5" decimals="-3" id="ixv-5241" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c6"
      decimals="INF"
      id="ixv-5242"
      unitRef="shares">4500</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c7"
      decimals="INF"
      id="ixv-5243"
      unitRef="shares">4500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c6"
      decimals="INF"
      id="ixv-5244"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c7"
      decimals="INF"
      id="ixv-5245"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c6"
      decimals="INF"
      id="ixv-5246"
      unitRef="shares">3600</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c6"
      decimals="INF"
      id="ixv-5247"
      unitRef="shares">3600</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c7"
      decimals="INF"
      id="ixv-5248"
      unitRef="shares">4500</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c7"
      decimals="INF"
      id="ixv-5249"
      unitRef="shares">4500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c6" decimals="-3" id="ixv-5250" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c7" decimals="-3" id="ixv-5251" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c2" decimals="-3" id="ixv-5252" unitRef="usd">135537000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c3" decimals="-3" id="ixv-5253" unitRef="usd">127804000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="-3" id="ixv-5254" unitRef="usd">-121108000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="-3" id="ixv-5255" unitRef="usd">-116319000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" id="ixv-5256" unitRef="usd">14434000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-3" id="ixv-5257" unitRef="usd">11490000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c2" decimals="-3" id="ixv-5258" unitRef="usd">16722000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="-3" id="ixv-5259" unitRef="usd">15418000</us-gaap:LiabilitiesAndStockholdersEquity>
    <wrap:RevenuesGross contextRef="c8" decimals="-3" id="ixv-5260" unitRef="usd">883000</wrap:RevenuesGross>
    <wrap:RevenuesGross contextRef="c9" decimals="-3" id="ixv-5261" unitRef="usd">309000</wrap:RevenuesGross>
    <wrap:RevenuesGross contextRef="c10" decimals="-3" id="ixv-5262" unitRef="usd">228000</wrap:RevenuesGross>
    <wrap:RevenuesGross contextRef="c11" decimals="-3" id="ixv-5263" unitRef="usd">456000</wrap:RevenuesGross>
    <us-gaap:Revenues contextRef="c0" decimals="-3" id="ixv-5264" unitRef="usd">1111000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c12" decimals="-3" id="ixv-5265" unitRef="usd">765000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c0" decimals="-3" id="ixv-5266" unitRef="usd">420000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c12" decimals="-3" id="ixv-5267" unitRef="usd">170000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c0" decimals="-3" id="ixv-5268" unitRef="usd">691000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c12" decimals="-3" id="ixv-5269" unitRef="usd">595000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c0" decimals="-3" id="ixv-5270" unitRef="usd">5355000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c12" decimals="-3" id="ixv-5271" unitRef="usd">4139000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" id="ixv-5272" unitRef="usd">105000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c12" decimals="-3" id="ixv-5273" unitRef="usd">378000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="c0" decimals="-3" id="ixv-5274" unitRef="usd">5460000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c12" decimals="-3" id="ixv-5275" unitRef="usd">4517000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" id="ixv-5276" unitRef="usd">-4769000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c12" decimals="-3" id="ixv-5277" unitRef="usd">-3922000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c0" decimals="-3" id="ixv-5278" unitRef="usd">1000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c12" decimals="-3" id="ixv-5279" unitRef="usd">2000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="-3" id="ixv-5280" unitRef="usd">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c12" decimals="-3" id="ixv-5281" unitRef="usd">-4029000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c0" decimals="-3" id="ixv-5282" unitRef="usd">227000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c12" decimals="-3" id="ixv-5283" unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c0" decimals="-3" id="ixv-5284" unitRef="usd">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c12" decimals="-3" id="ixv-5285" unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c0" decimals="-3" id="ixv-5286" unitRef="usd">229000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c12" decimals="-3" id="ixv-5287" unitRef="usd">4031000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-5288" unitRef="usd">-4540000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="-3" id="ixv-5289" unitRef="usd">109000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact contextRef="c0" decimals="-3" id="ixv-5290" unitRef="usd">249000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact contextRef="c12" decimals="-3" id="ixv-5291" unitRef="usd">164000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c0" decimals="-3" id="ixv-5292" unitRef="usd">-4789000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c12" decimals="-3" id="ixv-5293" unitRef="usd">-55000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-5294"
      unitRef="usdPershares">-0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-5295"
      unitRef="usdPershares">-0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c12"
      decimals="0"
      id="ixv-5296"
      unitRef="usdPershares">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c12"
      decimals="0"
      id="ixv-5297"
      unitRef="usdPershares">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c0" decimals="0" id="ixv-5298" unitRef="shares">54001602</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c0" decimals="0" id="ixv-5299" unitRef="shares">54001602</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c12"
      decimals="0"
      id="ixv-5300"
      unitRef="shares">48396271</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c12"
      decimals="0"
      id="ixv-5301"
      unitRef="shares">48396271</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-5302" unitRef="usd">-4540000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="-3" id="ixv-5303" unitRef="usd">109000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="-3" id="ixv-5304" unitRef="usd">-4540000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c12" decimals="-3" id="ixv-5305" unitRef="usd">109000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c13"
      decimals="INF"
      id="ixv-5306"
      unitRef="shares">51733217</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c13" decimals="-3" id="ixv-5307" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c14"
      decimals="INF"
      id="ixv-5308"
      unitRef="shares">8207</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c14" decimals="-3" id="ixv-5309" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c15"
      decimals="INF"
      id="ixv-5310"
      unitRef="shares">4500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c15" decimals="-3" id="ixv-5311" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c16" decimals="-3" id="ixv-5312" unitRef="usd">127804000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="-3" id="ixv-5313" unitRef="usd">-116319000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-3" id="ixv-5314" unitRef="usd">11490000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c18" decimals="-3" id="ixv-5315" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c19" decimals="-3" id="ixv-5316" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20" decimals="-3" id="ixv-5317" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c21" decimals="-3" id="ixv-5318" unitRef="usd">2384000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c22" decimals="-3" id="ixv-5319" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c0" decimals="-3" id="ixv-5320" unitRef="usd">2384000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <wrap:StockIssuedDuringPeriodSharesStockDividend
      contextRef="c18"
      decimals="INF"
      id="ixv-5321"
      unitRef="shares">462656</wrap:StockIssuedDuringPeriodSharesStockDividend>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c18" decimals="-3" id="ixv-5322" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodSharesStockDividend
      contextRef="c19"
      decimals="INF"
      id="ixv-5323"
      unitRef="shares">0</wrap:StockIssuedDuringPeriodSharesStockDividend>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c19" decimals="-3" id="ixv-5324" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodSharesStockDividend
      contextRef="c20"
      decimals="INF"
      id="ixv-5325"
      unitRef="shares">0</wrap:StockIssuedDuringPeriodSharesStockDividend>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c20" decimals="-3" id="ixv-5326" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c21" decimals="-3" id="ixv-5327" unitRef="usd">249000</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c22" decimals="-3" id="ixv-5328" unitRef="usd">-249000</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c0" decimals="-3" id="ixv-5329" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested
      contextRef="c18"
      decimals="INF"
      id="ixv-5330"
      unitRef="shares">72888</wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c18" decimals="-3" id="ixv-5331" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested
      contextRef="c19"
      decimals="INF"
      id="ixv-5332"
      unitRef="shares">0</wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c19" decimals="-3" id="ixv-5333" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested
      contextRef="c20"
      decimals="INF"
      id="ixv-5334"
      unitRef="shares">0</wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c20" decimals="-3" id="ixv-5335" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c21" decimals="-3" id="ixv-5336" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c22" decimals="-3" id="ixv-5337" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c0" decimals="-3" id="ixv-5338" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c18"
      decimals="INF"
      id="ixv-5339"
      unitRef="shares">668965</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c18" decimals="-3" id="ixv-5340" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c19"
      decimals="INF"
      id="ixv-5341"
      unitRef="shares">-100</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c19" decimals="-3" id="ixv-5342" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c20"
      decimals="INF"
      id="ixv-5343"
      unitRef="shares">-900</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c20" decimals="-3" id="ixv-5344" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c21" decimals="-3" id="ixv-5345" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c22" decimals="-3" id="ixv-5346" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c0" decimals="-3" id="ixv-5347" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement
      contextRef="c18"
      decimals="INF"
      id="ixv-5348"
      unitRef="shares">2500000</wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c18" decimals="-3" id="ixv-5349" unitRef="usd">0</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement
      contextRef="c19"
      decimals="INF"
      id="ixv-5350"
      unitRef="shares">0</wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c19" decimals="-3" id="ixv-5351" unitRef="usd">0</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement
      contextRef="c20"
      decimals="INF"
      id="ixv-5352"
      unitRef="shares">0</wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c20" decimals="-3" id="ixv-5353" unitRef="usd">0</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c21" decimals="-3" id="ixv-5354" unitRef="usd">5000000</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c22" decimals="-3" id="ixv-5355" unitRef="usd">0</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c0" decimals="-3" id="ixv-5356" unitRef="usd">5000000</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:StockIssuedDuringPeriodSharesWarrantExercised
      contextRef="c18"
      decimals="INF"
      id="ixv-5357"
      unitRef="shares">68966</wrap:StockIssuedDuringPeriodSharesWarrantExercised>
    <wrap:StockIssuedDuringPeriodValueWarrantExercised contextRef="c18" decimals="-3" id="ixv-5358" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueWarrantExercised>
    <wrap:StockIssuedDuringPeriodSharesWarrantExercised
      contextRef="c19"
      decimals="INF"
      id="ixv-5359"
      unitRef="shares">0</wrap:StockIssuedDuringPeriodSharesWarrantExercised>
    <wrap:StockIssuedDuringPeriodValueWarrantExercised contextRef="c19" decimals="-3" id="ixv-5360" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueWarrantExercised>
    <wrap:StockIssuedDuringPeriodSharesWarrantExercised
      contextRef="c20"
      decimals="INF"
      id="ixv-5361"
      unitRef="shares">0</wrap:StockIssuedDuringPeriodSharesWarrantExercised>
    <wrap:StockIssuedDuringPeriodValueWarrantExercised contextRef="c20" decimals="-3" id="ixv-5362" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueWarrantExercised>
    <wrap:StockIssuedDuringPeriodValueWarrantExercised contextRef="c21" decimals="-3" id="ixv-5363" unitRef="usd">100000</wrap:StockIssuedDuringPeriodValueWarrantExercised>
    <wrap:StockIssuedDuringPeriodValueWarrantExercised contextRef="c22" decimals="-3" id="ixv-5364" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueWarrantExercised>
    <wrap:StockIssuedDuringPeriodValueWarrantExercised contextRef="c0" decimals="-3" id="ixv-5365" unitRef="usd">100000</wrap:StockIssuedDuringPeriodValueWarrantExercised>
    <us-gaap:NetIncomeLoss contextRef="c18" decimals="-3" id="ixv-5366" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c19" decimals="-3" id="ixv-5367" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c20" decimals="-3" id="ixv-5368" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c21" decimals="-3" id="ixv-5369" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c22" decimals="-3" id="ixv-5370" unitRef="usd">-4540000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-5371" unitRef="usd">-4540000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c23"
      decimals="INF"
      id="ixv-5372"
      unitRef="shares">55506692</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c23" decimals="-3" id="ixv-5373" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c24"
      decimals="INF"
      id="ixv-5374"
      unitRef="shares">8107</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="-3" id="ixv-5375" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c25"
      decimals="INF"
      id="ixv-5376"
      unitRef="shares">3600</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="-3" id="ixv-5377" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c26" decimals="-3" id="ixv-5378" unitRef="usd">135537000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c27" decimals="-3" id="ixv-5379" unitRef="usd">-121108000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" id="ixv-5380" unitRef="usd">14434000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c28"
      decimals="INF"
      id="ixv-5381"
      unitRef="shares">47101631</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c28" decimals="-3" id="ixv-5382" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c29"
      decimals="INF"
      id="ixv-5383"
      unitRef="shares">8207</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c29" decimals="-3" id="ixv-5384" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c30"
      decimals="INF"
      id="ixv-5385"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c30" decimals="-3" id="ixv-5386" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c31" decimals="-3" id="ixv-5387" unitRef="usd">105326000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c32" decimals="-3" id="ixv-5388" unitRef="usd">-105081000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c33" decimals="-3" id="ixv-5389" unitRef="usd">250000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c34" decimals="-3" id="ixv-5390" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c35" decimals="-3" id="ixv-5391" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c36" decimals="-3" id="ixv-5392" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c37" decimals="-3" id="ixv-5393" unitRef="usd">1665000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c38" decimals="-3" id="ixv-5394" unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c12" decimals="-3" id="ixv-5395" unitRef="usd">1665000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <wrap:StockIssuedDuringPeriodSharesStockDividend
      contextRef="c34"
      decimals="INF"
      id="ixv-5396"
      unitRef="shares">113205</wrap:StockIssuedDuringPeriodSharesStockDividend>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c34" decimals="-3" id="ixv-5397" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodSharesStockDividend
      contextRef="c35"
      decimals="INF"
      id="ixv-5398"
      unitRef="shares">0</wrap:StockIssuedDuringPeriodSharesStockDividend>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c35" decimals="-3" id="ixv-5399" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodSharesStockDividend
      contextRef="c36"
      decimals="INF"
      id="ixv-5400"
      unitRef="shares">0</wrap:StockIssuedDuringPeriodSharesStockDividend>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c36" decimals="-3" id="ixv-5401" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c37" decimals="-3" id="ixv-5402" unitRef="usd">164000</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c38" decimals="-3" id="ixv-5403" unitRef="usd">-164000</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodValueStockDividends contextRef="c12" decimals="-3" id="ixv-5404" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueStockDividends>
    <wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested
      contextRef="c34"
      decimals="INF"
      id="ixv-5405"
      unitRef="shares">63199</wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c34" decimals="-3" id="ixv-5406" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested
      contextRef="c35"
      decimals="INF"
      id="ixv-5407"
      unitRef="shares">0</wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c35" decimals="-3" id="ixv-5408" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested
      contextRef="c36"
      decimals="INF"
      id="ixv-5409"
      unitRef="shares">0</wrap:StockIssuedDuringPeriodSharesRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c36" decimals="-3" id="ixv-5410" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c37" decimals="-3" id="ixv-5411" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c38" decimals="-3" id="ixv-5412" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested contextRef="c12" decimals="-3" id="ixv-5413" unitRef="usd">0</wrap:StockIssuedDuringPeriodValueRestrictedStockUnitsVested>
    <wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement
      contextRef="c34"
      decimals="INF"
      id="ixv-5414"
      unitRef="shares">3216666</wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c34" decimals="-3" id="ixv-5415" unitRef="usd">0</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement
      contextRef="c35"
      decimals="INF"
      id="ixv-5416"
      unitRef="shares">0</wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c35" decimals="-3" id="ixv-5417" unitRef="usd">0</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement
      contextRef="c36"
      decimals="INF"
      id="ixv-5418"
      unitRef="shares">0</wrap:CommonStockSharesAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c36" decimals="-3" id="ixv-5419" unitRef="usd">0</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c37" decimals="-3" id="ixv-5420" unitRef="usd">543000</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c38" decimals="-3" id="ixv-5421" unitRef="usd">0</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement contextRef="c12" decimals="-3" id="ixv-5422" unitRef="usd">543000</wrap:CommonStockAndPrefundedWarrantsIssuedWithPrivatePlacement>
    <us-gaap:NetIncomeLoss contextRef="c34" decimals="-3" id="ixv-5423" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c35" decimals="-3" id="ixv-5424" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c36" decimals="-3" id="ixv-5425" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c37" decimals="-3" id="ixv-5426" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c38" decimals="-3" id="ixv-5427" unitRef="usd">109000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="-3" id="ixv-5428" unitRef="usd">109000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c39"
      decimals="INF"
      id="ixv-5429"
      unitRef="shares">50494701</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c39" decimals="-3" id="ixv-5430" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c40"
      decimals="INF"
      id="ixv-5431"
      unitRef="shares">8207</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c40" decimals="-3" id="ixv-5432" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c41"
      decimals="INF"
      id="ixv-5433"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c41" decimals="-3" id="ixv-5434" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c42" decimals="-3" id="ixv-5435" unitRef="usd">107698000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c43" decimals="-3" id="ixv-5436" unitRef="usd">-105136000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c44" decimals="-3" id="ixv-5437" unitRef="usd">2567000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-5438" unitRef="usd">-4540000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="-3" id="ixv-5439" unitRef="usd">109000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization contextRef="c0" decimals="-3" id="ixv-5440" unitRef="usd">56000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c12" decimals="-3" id="ixv-5441" unitRef="usd">155000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-5442" unitRef="usd">2384000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c12" decimals="-3" id="ixv-5443" unitRef="usd">1665000</us-gaap:ShareBasedCompensation>
    <wrap:ProductWarrantyExpenseIncome contextRef="c0" decimals="-3" id="ixv-5444" unitRef="usd">4000</wrap:ProductWarrantyExpenseIncome>
    <wrap:ProductWarrantyExpenseIncome contextRef="c12" decimals="-3" id="ixv-5445" unitRef="usd">2000</wrap:ProductWarrantyExpenseIncome>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c0" decimals="-3" id="ixv-5446" unitRef="usd">227000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease contextRef="c12" decimals="-3" id="ixv-5447" unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="-3" id="ixv-5448" unitRef="usd">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c12" decimals="-3" id="ixv-5449" unitRef="usd">-4029000</us-gaap:FairValueAdjustmentOfWarrants>
    <wrap:NoncashLeaseExpense contextRef="c0" decimals="-3" id="ixv-5450" unitRef="usd">54000</wrap:NoncashLeaseExpense>
    <wrap:NoncashLeaseExpense contextRef="c12" decimals="-3" id="ixv-5451" unitRef="usd">74000</wrap:NoncashLeaseExpense>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c0" decimals="-3" id="ixv-5452" unitRef="usd">-1000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c12" decimals="-3" id="ixv-5453" unitRef="usd">37000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryWriteDown contextRef="c0" decimals="-3" id="ixv-5454" unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="c12" decimals="-3" id="ixv-5455" unitRef="usd">18000</us-gaap:InventoryWriteDown>
    <wrap:IncreaseDecreaseInAccountsReceivableAndContractAssets contextRef="c0" decimals="-3" id="ixv-5456" unitRef="usd">-797000</wrap:IncreaseDecreaseInAccountsReceivableAndContractAssets>
    <wrap:IncreaseDecreaseInAccountsReceivableAndContractAssets contextRef="c12" decimals="-3" id="ixv-5457" unitRef="usd">184000</wrap:IncreaseDecreaseInAccountsReceivableAndContractAssets>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c0" decimals="-3" id="ixv-5458" unitRef="usd">-326000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c12" decimals="-3" id="ixv-5459" unitRef="usd">-71000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c0" decimals="-3" id="ixv-5460" unitRef="usd">380000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c12" decimals="-3" id="ixv-5461" unitRef="usd">404000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c0" decimals="-3" id="ixv-5462" unitRef="usd">167000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c12" decimals="-3" id="ixv-5463" unitRef="usd">-115000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c0" decimals="-3" id="ixv-5464" unitRef="usd">-57000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c12" decimals="-3" id="ixv-5465" unitRef="usd">-74000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="c0" decimals="-3" id="ixv-5466" unitRef="usd">11000</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="c12" decimals="-3" id="ixv-5467" unitRef="usd">0</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c0" decimals="-3" id="ixv-5468" unitRef="usd">122000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c12" decimals="-3" id="ixv-5469" unitRef="usd">-272000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <wrap:IncreaseDecreaseInWarrantySettlements contextRef="c0" decimals="-3" id="ixv-5470" unitRef="usd">-2000</wrap:IncreaseDecreaseInWarrantySettlements>
    <wrap:IncreaseDecreaseInWarrantySettlements contextRef="c12" decimals="-3" id="ixv-5471" unitRef="usd">-7000</wrap:IncreaseDecreaseInWarrantySettlements>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c0" decimals="-3" id="ixv-5472" unitRef="usd">38000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c12" decimals="-3" id="ixv-5473" unitRef="usd">-155000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c0" decimals="-3" id="ixv-5474" unitRef="usd">-24000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c12" decimals="-3" id="ixv-5475" unitRef="usd">-40000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" id="ixv-5476" unitRef="usd">-1246000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c12" decimals="-3" id="ixv-5477" unitRef="usd">-3069000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-5478" unitRef="usd">5000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c12" decimals="-3" id="ixv-5479" unitRef="usd">2000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c0" decimals="-3" id="ixv-5480" unitRef="usd">53000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c12" decimals="-3" id="ixv-5481" unitRef="usd">44000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c0" decimals="-3" id="ixv-5482" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c12" decimals="-3" id="ixv-5483" unitRef="usd">54000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" id="ixv-5484" unitRef="usd">-58000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c12" decimals="-3" id="ixv-5485" unitRef="usd">-100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c0" decimals="-3" id="ixv-5486" unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c12" decimals="-3" id="ixv-5487" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c0" decimals="-3" id="ixv-5488" unitRef="usd">100000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c12" decimals="-3" id="ixv-5489" unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <wrap:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="c0" decimals="-3" id="ixv-5490" unitRef="usd">0</wrap:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
    <wrap:ProceedsFromIssuanceOfCommonStockAndWarrantsNet contextRef="c12" decimals="-3" id="ixv-5491" unitRef="usd">5729000</wrap:ProceedsFromIssuanceOfCommonStockAndWarrantsNet>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" id="ixv-5492" unitRef="usd">5100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c12" decimals="-3" id="ixv-5493" unitRef="usd">5729000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c0" decimals="-3" id="ixv-5494" unitRef="usd">3796000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c12" decimals="-3" id="ixv-5495" unitRef="usd">2560000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c3" decimals="-3" id="ixv-5496" unitRef="usd">3468000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c33" decimals="-3" id="ixv-5497" unitRef="usd">3610000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c2" decimals="-3" id="ixv-5498" unitRef="usd">7264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c44" decimals="-3" id="ixv-5499" unitRef="usd">6170000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <wrap:ConvertiblePreferredStockDividends contextRef="c0" decimals="-3" id="ixv-5500" unitRef="usd">-249000</wrap:ConvertiblePreferredStockDividends>
    <wrap:ConvertiblePreferredStockDividends contextRef="c12" decimals="-3" id="ixv-5501" unitRef="usd">-164000</wrap:ConvertiblePreferredStockDividends>
    <wrap:DividendsSettledWithCommonStock contextRef="c0" decimals="-3" id="ixv-5502" unitRef="usd">249000</wrap:DividendsSettledWithCommonStock>
    <wrap:DividendsSettledWithCommonStock contextRef="c12" decimals="-3" id="ixv-5503" unitRef="usd">164000</wrap:DividendsSettledWithCommonStock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c0" id="ixv-2359">&lt;p id="xdx_802_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_z9Rk19gcvcsh" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;1. &lt;span id="xdx_823_zNLQhQBAhwsd"&gt;ORGANIZATION, SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT DEVELOPMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_846_ecustom--OrganizationAndBusinessDescriptionPolicyTextBlock_za9INplApsl6" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Organization and Business Description&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Wrap Technologies, Inc., a Delaware corporation (the &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, and &#x201c;our&#x201d;), is a publicly traded company with its common stock, par value $&lt;span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20250630_z4HpQzBNuiX7" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share (&#x201c;Common Stock&#x201d;), listed on the Nasdaq Capital Market (&#x201c;Nasdaq&#x201d;) under the trading symbol &#x201c;WRAP.&#x201d; The Company is a developer and supplier of public safety products and training services for law enforcement and security personnel. The Company's product and service portfolio also includes Wrap Reality, a virtual reality training simulator, WrapTactics&#x2122;, a subscription-based digital training platform, WrapVision&#x2122;, a body-worn camera and digital evidence management solution, and technology-enabled services including managed services and policy support. The principal markets for the Company's proprietary products and services are in North and South America, Europe, the Middle East, and Asia.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_840_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zcYt58qpVaM4" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company&#x2019;s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to
      Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (&#x201c;&lt;i&gt;SEC&lt;/i&gt;&#x201d;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S.
      generally accepted accounting principles (&#x201c;&lt;i&gt;U.S. GAAP&lt;/i&gt;&#x201d;) have been condensed or omitted pursuant to such rules and regulations. In management&#x2019;s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the
      financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise
      disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company&#x2019;s audited financial statements and notes thereto for the year ended December 31, 2025, included in the
      Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025 (the &#x201c;&lt;i&gt;Annual Report&lt;/i&gt;&#x201d;), as filed with the SEC on March 26, 2026. The accompanying unaudited condensed consolidated balance sheet as of March 31, 2026 has been derived from the audited consolidated balance sheet as of December 31, 2025, contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2025. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.&lt;/p&gt;


    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_844_eus-gaap--ConsolidationPolicyTextBlock_zRfEfSQKEPEe" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company has &lt;span id="xdx_902_ecustom--NumberOfWhollyOwnedSubsidiaries_iI_dc_uInteger_c20250630_z9BJYYCqGBTf" title="Number of wholly-owned subsidiaries"&gt;three&lt;/span&gt; wholly owned subsidiaries, Wrap Reality, Inc., that sells a virtual reality (&#x201c;&lt;i&gt;VR&lt;/i&gt;&#x201d;) training system primarily targeting law enforcement agencies, Intrensic, LLC (&#x201c;Intrensic&#x201d;), specializing in Body Worn Camera and Digital Evidence Management solutions and Wrap Federal, LLC, formed to support federal government clients in federal agencies. The condensed consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_842_ecustom--SegmentAndRelatedInformationPolicyTextBlock_z2euPdQFqrsg" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Segment and Related Information&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company operates as a &lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-3"&gt;single&lt;/span&gt;&lt;/span&gt; operating and reportable segment. The Company's Chief Operating Decision Maker is its Chief Executive Officer, who manages operations for purposes of allocating resources on a consolidated basis.&lt;/p&gt;&lt;div&gt;
    &lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zud4SIsdupHe" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;


    &lt;p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zA5uvOOAFhd9" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company recognizes revenue under ASC Topic 606 - Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). Revenue is recognized when control of promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to receive. The Company's revenues consist of product sales (BolaWrap devices, cassettes, and accessories) and technology-enabled services (software subscriptions, body-worn cameras, managed services, policy support, training, and shipping). &lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;

    &lt;p style="font: bold 10pt &amp;quot;Times New Roman&amp;quot;; margin-top: 0pt; margin-bottom: 0pt;"&gt;Warrants&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt;"&gt;As of March 31, 2026, all outstanding warrants (Series A Warrants, PIPE Warrants, Series B Warrants, and February 2026 Warrants each defined herein) are classified within permanent equity (additional paid-in capital) following amendments executed on June 30, 2025 that enabled equity classification under ASC 815-40 as discussed further in Note 8. These warrants are not subject to subsequent fair value remeasurement and no warrant liability is recorded as of March 31, 2026 or December 31, 2025.&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;




    &lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_ztarpDhZ8gA4" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Loss per Share&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Basic loss per share (EPS) is computed by dividing net loss, less any dividends, accretion or decretion, redemption or induced conversion, if any, on the
      Company&#x2019;s Series A Convertible Preferred Stock ("Series A Preferred Stock"), by the weighted average number of shares outstanding during the reported period.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;In computing diluted EPS, the Company adjusts the numerator used in the basic EPS computation, subject to anti-dilution requirements, to add back the dividends (declared or cumulative undeclared) applicable to the Series A and Series B Convertible Preferred Stock. Such add-back would also include any adjustments to equity in the period to accrete the Series A and Series B Convertible Preferred Stock to its redemption price, or recorded upon a redemption or induced conversion, if any. The Company adjusts the denominator used in the basic EPS computation, subject to anti-dilution requirements, to include the dilution from potential shares resulting from the issuance of the Series A and Series B Convertible Preferred Stock, restricted stock units, and stock options. Stock options and restricted stock units exercisable or issuable for a total &lt;span style="background-color: rgb(255, 255, 255);"&gt;of 11,369,761 shares and &lt;span id="xdx_90C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240101__20240630_zeoBNTeRAyK8" title="Antidilutive securities excluded from computation of earnings per share,         amount"&gt;7,595,515&lt;/span&gt;&#160;sh&lt;/span&gt;ares of Common Stock were outstanding as of March 31, 2026 and 2025, respectively. These securities are not included in the computation of diluted net loss per share of Common Stock for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Reclassifications&lt;/b&gt;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net loss, total assets, total liabilities, stockholders&#x2019; equity, or cash flows.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160; &#160;&lt;/p&gt;


    &lt;p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlHJBf9iCYi" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Recently Issued Accounting Guidance Not Yet Effective&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;In November 2024, the FASB issued ASU 2024-03, which requires disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact of ASU 2024-03 on its financial statements.&lt;/p&gt;&lt;p id="xdx_851_zjg3JsRcN7r3" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <wrap:OrganizationAndBusinessDescriptionPolicyTextBlock contextRef="c0" id="ixv-2364">&lt;p id="xdx_846_ecustom--OrganizationAndBusinessDescriptionPolicyTextBlock_za9INplApsl6" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Organization and Business Description&lt;/b&gt;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Wrap Technologies, Inc., a Delaware corporation (the &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, and &#x201c;our&#x201d;), is a publicly traded company with its common stock, par value $&lt;span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20250630_z4HpQzBNuiX7" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share (&#x201c;Common Stock&#x201d;), listed on the Nasdaq Capital Market (&#x201c;Nasdaq&#x201d;) under the trading symbol &#x201c;WRAP.&#x201d; The Company is a developer and supplier of public safety products and training services for law enforcement and security personnel. The Company's product and service portfolio also includes Wrap Reality, a virtual reality training simulator, WrapTactics&#x2122;, a subscription-based digital training platform, WrapVision&#x2122;, a body-worn camera and digital evidence management solution, and technology-enabled services including managed services and policy support. The principal markets for the Company's proprietary products and services are in North and South America, Europe, the Middle East, and Asia.&lt;/p&gt;</wrap:OrganizationAndBusinessDescriptionPolicyTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c2"
      decimals="INF"
      id="ixv-5504"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c3"
      decimals="INF"
      id="ixv-5505"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-2372">&lt;p id="xdx_840_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zcYt58qpVaM4" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company&#x2019;s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to
      Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (&#x201c;&lt;i&gt;SEC&lt;/i&gt;&#x201d;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S.
      generally accepted accounting principles (&#x201c;&lt;i&gt;U.S. GAAP&lt;/i&gt;&#x201d;) have been condensed or omitted pursuant to such rules and regulations. In management&#x2019;s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the
      financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise
      disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company&#x2019;s audited financial statements and notes thereto for the year ended December 31, 2025, included in the
      Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025 (the &#x201c;&lt;i&gt;Annual Report&lt;/i&gt;&#x201d;), as filed with the SEC on March 26, 2026. The accompanying unaudited condensed consolidated balance sheet as of March 31, 2026 has been derived from the audited consolidated balance sheet as of December 31, 2025, contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2025. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0" id="ixv-2382">&lt;p id="xdx_844_eus-gaap--ConsolidationPolicyTextBlock_zRfEfSQKEPEe" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Principles of Consolidation&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company has &lt;span id="xdx_902_ecustom--NumberOfWhollyOwnedSubsidiaries_iI_dc_uInteger_c20250630_z9BJYYCqGBTf" title="Number of wholly-owned subsidiaries"&gt;three&lt;/span&gt; wholly owned subsidiaries, Wrap Reality, Inc., that sells a virtual reality (&#x201c;&lt;i&gt;VR&lt;/i&gt;&#x201d;) training system primarily targeting law enforcement agencies, Intrensic, LLC (&#x201c;Intrensic&#x201d;), specializing in Body Worn Camera and Digital Evidence Management solutions and Wrap Federal, LLC, formed to support federal government clients in federal agencies. The condensed consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <wrap:NumberOfWhollyOwnedSubsidiaries
      contextRef="c2"
      decimals="INF"
      id="ixv-5506"
      unitRef="Subsidiary">3</wrap:NumberOfWhollyOwnedSubsidiaries>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c0" id="ixv-2391">&lt;p id="xdx_842_ecustom--SegmentAndRelatedInformationPolicyTextBlock_z2euPdQFqrsg" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Segment and Related Information&lt;/b&gt;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company operates as a &lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-3"&gt;single&lt;/span&gt;&lt;/span&gt; operating and reportable segment. The Company's Chief Operating Decision Maker is its Chief Executive Officer, who manages operations for purposes of allocating resources on a consolidated basis.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-2403">&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zud4SIsdupHe" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c0" id="ixv-2419">&lt;p id="xdx_842_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zA5uvOOAFhd9" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company recognizes revenue under ASC Topic 606 - Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). Revenue is recognized when control of promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to receive. The Company's revenues consist of product sales (BolaWrap devices, cassettes, and accessories) and technology-enabled services (software subscriptions, body-worn cameras, managed services, policy support, training, and shipping). &lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <wrap:ClassificationAndValuationOfWarrantsPolicyTextBlock contextRef="c0" id="ixv-2427">&lt;p style="font: bold 10pt &amp;quot;Times New Roman&amp;quot;; margin-top: 0pt; margin-bottom: 0pt;"&gt;Warrants&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt;"&gt;As of March 31, 2026, all outstanding warrants (Series A Warrants, PIPE Warrants, Series B Warrants, and February 2026 Warrants each defined herein) are classified within permanent equity (additional paid-in capital) following amendments executed on June 30, 2025 that enabled equity classification under ASC 815-40 as discussed further in Note 8. These warrants are not subject to subsequent fair value remeasurement and no warrant liability is recorded as of March 31, 2026 or December 31, 2025.&lt;/p&gt;</wrap:ClassificationAndValuationOfWarrantsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-2434">&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_ztarpDhZ8gA4" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Loss per Share&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Basic loss per share (EPS) is computed by dividing net loss, less any dividends, accretion or decretion, redemption or induced conversion, if any, on the
      Company&#x2019;s Series A Convertible Preferred Stock ("Series A Preferred Stock"), by the weighted average number of shares outstanding during the reported period.&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;In computing diluted EPS, the Company adjusts the numerator used in the basic EPS computation, subject to anti-dilution requirements, to add back the dividends (declared or cumulative undeclared) applicable to the Series A and Series B Convertible Preferred Stock. Such add-back would also include any adjustments to equity in the period to accrete the Series A and Series B Convertible Preferred Stock to its redemption price, or recorded upon a redemption or induced conversion, if any. The Company adjusts the denominator used in the basic EPS computation, subject to anti-dilution requirements, to include the dilution from potential shares resulting from the issuance of the Series A and Series B Convertible Preferred Stock, restricted stock units, and stock options. Stock options and restricted stock units exercisable or issuable for a total &lt;span style="background-color: rgb(255, 255, 255);"&gt;of 11,369,761 shares and &lt;span id="xdx_90C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20240101__20240630_zeoBNTeRAyK8" title="Antidilutive securities excluded from computation of earnings per share,         amount"&gt;7,595,515&lt;/span&gt;&#160;sh&lt;/span&gt;ares of Common Stock were outstanding as of March 31, 2026 and 2025, respectively. These securities are not included in the computation of diluted net loss per share of Common Stock for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c0"
      decimals="INF"
      id="ixv-5507"
      unitRef="shares">11369761</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c12"
      decimals="INF"
      id="ixv-5508"
      unitRef="shares">7595515</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c0" id="ixv-2446">&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Reclassifications&lt;/b&gt;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net loss, total assets, total liabilities, stockholders&#x2019; equity, or cash flows.&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0" id="ixv-2453">&lt;p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlHJBf9iCYi" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Recently Issued Accounting Guidance Not Yet Effective&lt;/b&gt;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;In November 2024, the FASB issued ASU 2024-03, which requires disaggregated disclosure of income statement expenses for public business entities. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact of ASU 2024-03 on its financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c0" id="ixv-2460">&lt;div&gt;
    &lt;p id="xdx_808_eus-gaap--RevenueFromContractWithCustomerTextBlock_z6pcWuyPC44h" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;2. &lt;span id="xdx_824_zO3LHCm9u2J"&gt;REVENUE AND PRODUCT COSTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Revenues consist of product sales and technology-enabled services. Product sales include BolaWrap devices, cassettes, and accessories. Technology-enabled services include software subscriptions, body-worn cameras, managed services, policy and training support, and shipping revenue.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;/div&gt;&lt;div&gt;
    &lt;p id="xdx_894_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zCttMYt4Olu4" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The table below details the activity in our contract liabilities during the three months ended March 31, 2026.&lt;/p&gt;



    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span id="xdx_8BE_zcWFvXjWEzIc" style="display: none"&gt;SCHEDULE OF CONTRACT LIABILITIES&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - C3"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - C3"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - E3"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - E3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - C4"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center;"&gt;Customer Deposits&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E4"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center;"&gt;Deferred Revenue&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Balance at January 1, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;62&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;422&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding-left: 10px;"&gt;Additions, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;19&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;259&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;Transfer to revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(30&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C8"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(221&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E8"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Balance at March 31, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - C9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;51&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;460&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - E10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Current portion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;51&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;449&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Long-term portion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;11&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p id="xdx_8AC_zLscB1ibma18" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;As of March 31, 2026, the Company&#x2019;s deferred revenue of $460 consisted of $9 related to BolaWrap extended warranties and services, $27 related to WRAP Ready, $379 related to Intrensic extended warranties and services, $21 related to VR, $14 related to training and $10 related to WrapTactics.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c0" id="ixv-2469">&lt;p id="xdx_894_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zCttMYt4Olu4" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The table below details the activity in our contract liabilities during the three months ended March 31, 2026.&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - C3"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - C3"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - E3"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - E3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - C4"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center;"&gt;Customer Deposits&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E4"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center;"&gt;Deferred Revenue&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Balance at January 1, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;62&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;422&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="padding-left: 10px;"&gt;Additions, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;19&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;259&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td style="padding-left: 10px;"&gt;Transfer to revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(30&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C8"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(221&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E8"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Balance at March 31, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - C9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;51&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E9"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;460&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 2 Revenues  Product Costs - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - E10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 2 Revenues  Product Costs - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Current portion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;51&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;449&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Long-term portion&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;11&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 2 Revenues  Product Costs - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability contextRef="c52" decimals="-3" id="ixv-5509" unitRef="usd">62000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c53" decimals="-3" id="ixv-5510" unitRef="usd">422000</us-gaap:ContractWithCustomerLiability>
    <wrap:ContractWithCustomerLiabilityAddition contextRef="c54" decimals="-3" id="ixv-5511" unitRef="usd">19000</wrap:ContractWithCustomerLiabilityAddition>
    <wrap:ContractWithCustomerLiabilityAddition contextRef="c55" decimals="-3" id="ixv-5512" unitRef="usd">259000</wrap:ContractWithCustomerLiabilityAddition>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c54" decimals="-3" id="ixv-5513" unitRef="usd">-30000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c55" decimals="-3" id="ixv-5514" unitRef="usd">-221000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability contextRef="c56" decimals="-3" id="ixv-5515" unitRef="usd">51000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c45" decimals="-3" id="ixv-5516" unitRef="usd">460000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c56" decimals="-3" id="ixv-5517" unitRef="usd">51000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c45" decimals="-3" id="ixv-5518" unitRef="usd">449000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c56" decimals="-3" id="ixv-5519" unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c45" decimals="-3" id="ixv-5520" unitRef="usd">11000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiability contextRef="c45" decimals="-3" id="ixv-5521" unitRef="usd">460000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c46" decimals="-3" id="ixv-5522" unitRef="usd">9000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c47" decimals="-3" id="ixv-5523" unitRef="usd">27000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c48" decimals="-3" id="ixv-5524" unitRef="usd">379000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c49" decimals="-3" id="ixv-5525" unitRef="usd">21000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c50" decimals="-3" id="ixv-5526" unitRef="usd">14000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c51" decimals="-3" id="ixv-5527" unitRef="usd">10000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock contextRef="c0" id="ixv-2576">&lt;div&gt;
    &lt;p id="xdx_803_eus-gaap--FinancialInstrumentsDisclosureTextBlock_zNGbl1Ra3Ffg" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;3. &lt;span id="xdx_82A_zO4WXiP8bYW9"&gt;FINANCIAL INSTRUMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Assets and liabilities recorded at fair value on a recurring basis in the Condensed Consolidated Balance Sheets and assets and liabilities measured at
      fair value on a non-recurring basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair
      value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in an orderly transaction between market
      participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or
      unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly
      summarized as follows:&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;i&gt;Level 1&lt;/i&gt;-Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/p&gt;


    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt; &lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;i&gt; &lt;/i&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;i&gt;Level 2&lt;/i&gt;-Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for
      identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;i&gt;Level 3&lt;/i&gt;-Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or
      no market data.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;
    &lt;p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zUPN8pak1Fk6" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The following table shows the Company&#x2019;s short-term investments by significant investment category as of March 31, 2026, and December 31, 2025.&lt;/p&gt;



    &lt;p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zUPN8pak1Fk6-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="15" style="text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold;"&gt;As of March 31, 2026&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Adjusted
Cost&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Unrealized
Gains&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Unrealized
Losses&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Market
Value&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Level 1:&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - B6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - B6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - D6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - D6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - F6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - F6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - H6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - H6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Money Market Funds&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;640&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;640&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Total financial assets&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;640&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;640&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="15" style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;As of December 31, 2025&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B11"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Adjusted
Cost&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D11"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Unrealized
Gains&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F11"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Unrealized
Losses&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H11"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Market
Value&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Level 1:&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - B12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - B12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - D12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - D12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - F12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - F12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - H12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - H12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Money Market Funds&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;639&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;639&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H13"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Total financial assets&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;639&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;639&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H14"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

    &lt;p id="xdx_8A9_zIWDQ6NkPAw2" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;
    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;As of March 31, 2026 and December 31, 2025, the Company has no warrant liabilities. All outstanding warrants are classified within permanent equity following amendments completed on June 30, 2025. Refer to Note 8 for further discussion.
Other financial instruments, including accounts receivable, accounts payable, accrued liabilities and customer deposits, are carried at cost which approximates fair value due to their short-term nature.
&lt;/p&gt;









    &lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="c0" id="ixv-2596">&lt;div&gt;
    &lt;p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zUPN8pak1Fk6" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The following table shows the Company&#x2019;s short-term investments by significant investment category as of March 31, 2026, and December 31, 2025.&lt;/p&gt;



    &lt;p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zUPN8pak1Fk6-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="15" style="text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold;"&gt;As of March 31, 2026&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Adjusted
Cost&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Unrealized
Gains&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Unrealized
Losses&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Market
Value&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Level 1:&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - B6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - B6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - D6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - D6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - F6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - F6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - H6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - H6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Money Market Funds&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;640&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;640&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Total financial assets&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;640&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;640&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="15" style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;As of December 31, 2025&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B11"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Adjusted
Cost&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D11"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Unrealized
Gains&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F11"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Unrealized
Losses&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H11"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Market
Value&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Level 1:&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - B12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - B12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - D12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - D12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - F12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - F12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - H12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 3 Financial Instruments - H12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Money Market Funds&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;639&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H13"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;639&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H13"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Total financial assets&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;639&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - B14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - D14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - F14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;639&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 3 Financial Instruments - H14"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

    &lt;p id="xdx_8A9_zIWDQ6NkPAw2" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <wrap:FinancialInstrumentsOwnedAdjustedCost contextRef="c57" decimals="-3" id="ixv-5528" unitRef="usd">640000</wrap:FinancialInstrumentsOwnedAdjustedCost>
    <wrap:FairValueAssetRecurringBasisStillHeldUnrealizedGain contextRef="c58" decimals="-3" id="ixv-5529" unitRef="usd">0</wrap:FairValueAssetRecurringBasisStillHeldUnrealizedGain>
    <wrap:FairValueAssetRecurringBasisStillHeldUnrealizedLoss contextRef="c58" decimals="-3" id="ixv-5530" unitRef="usd">0</wrap:FairValueAssetRecurringBasisStillHeldUnrealizedLoss>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="c57" decimals="-3" id="ixv-5531" unitRef="usd">640000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <wrap:FinancialInstrumentsOwnedAdjustedCost contextRef="c59" decimals="-3" id="ixv-5532" unitRef="usd">640000</wrap:FinancialInstrumentsOwnedAdjustedCost>
    <wrap:FairValueAssetRecurringBasisStillHeldUnrealizedGain contextRef="c60" decimals="-3" id="ixv-5533" unitRef="usd">0</wrap:FairValueAssetRecurringBasisStillHeldUnrealizedGain>
    <wrap:FairValueAssetRecurringBasisStillHeldUnrealizedLoss contextRef="c60" decimals="-3" id="ixv-5534" unitRef="usd">0</wrap:FairValueAssetRecurringBasisStillHeldUnrealizedLoss>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="c59" decimals="-3" id="ixv-5535" unitRef="usd">640000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <wrap:FinancialInstrumentsOwnedAdjustedCost contextRef="c61" decimals="-3" id="ixv-5536" unitRef="usd">639000</wrap:FinancialInstrumentsOwnedAdjustedCost>
    <wrap:FairValueAssetRecurringBasisStillHeldUnrealizedGain contextRef="c62" decimals="-3" id="ixv-5537" unitRef="usd">0</wrap:FairValueAssetRecurringBasisStillHeldUnrealizedGain>
    <wrap:FairValueAssetRecurringBasisStillHeldUnrealizedLoss contextRef="c62" decimals="-3" id="ixv-5538" unitRef="usd">0</wrap:FairValueAssetRecurringBasisStillHeldUnrealizedLoss>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="c61" decimals="-3" id="ixv-5539" unitRef="usd">639000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <wrap:FinancialInstrumentsOwnedAdjustedCost contextRef="c63" decimals="-3" id="ixv-5540" unitRef="usd">639000</wrap:FinancialInstrumentsOwnedAdjustedCost>
    <wrap:FairValueAssetRecurringBasisStillHeldUnrealizedGain contextRef="c64" decimals="-3" id="ixv-5541" unitRef="usd">0</wrap:FairValueAssetRecurringBasisStillHeldUnrealizedGain>
    <wrap:FairValueAssetRecurringBasisStillHeldUnrealizedLoss contextRef="c64" decimals="-3" id="ixv-5542" unitRef="usd">0</wrap:FairValueAssetRecurringBasisStillHeldUnrealizedLoss>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="c63" decimals="-3" id="ixv-5543" unitRef="usd">639000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:DerivativeLiabilities contextRef="c2" decimals="-3" id="ixv-5544" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c3" decimals="-3" id="ixv-5545" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c0" id="ixv-2790">&lt;div&gt;
    &lt;p id="xdx_80B_eus-gaap--InventoryDisclosureTextBlock_zKeog42AtFsc" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;4. &lt;span id="xdx_821_zrPbiZbajRme"&gt;INVENTORIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z3jKjgtX4Ae1" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Inventory is recorded at the lower of cost or net realizable value using the weighted average cost method. Inventories consisted of the following:&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;span id="xdx_8B4_zZYS7UM68Ss7" style="display: none"&gt;SCHEDULE OF INVENTORY&lt;/span&gt;&lt;/p&gt;


    &lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - C4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center; width: 9%;"&gt;March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - C4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;December 31, 2025&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 4 Inventory - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 4 Inventory - C5"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 4 Inventory - E5"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 4 Inventory - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Finished goods&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - C6"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;3,198&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - C6"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - E6"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;3,509&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Raw materials&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - D7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;1,963&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - D7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium; border-style: none; border-color: currentcolor; width: 1%;" title="FN 4 Inventory - E7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor; width: 9%;"&gt;1,978&lt;/td&gt;&lt;td style="text-align: left; border-width: medium; border-style: none; border-color: currentcolor; width: 1%;" title="FN 4 Inventory - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Reserve for obsolescence&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - D8"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(516&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - D8"&gt;)&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E8"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;(516&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E8"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Inventories, net&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - D9"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;4,645&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - D9"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E9"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;4,971&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p id="xdx_8A0_zESm2vtYUxda" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; text-align: justify; margin-top: 0pt; margin-bottom: 0pt;"&gt;Inventory reserve expense was $0 and $18 for the three months ended March 31, 2026 and 2025, respectively.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c0" id="ixv-2796">&lt;p id="xdx_896_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z3jKjgtX4Ae1" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Inventory is recorded at the lower of cost or net realizable value using the weighted average cost method. Inventories consisted of the following:&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="white-space : nowrap; "&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - C4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center; width: 9%;"&gt;March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - C4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;December 31, 2025&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 4 Inventory - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 4 Inventory - C5"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 4 Inventory - E5"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 4 Inventory - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Finished goods&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - C6"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;3,198&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - C6"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - E6"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;3,509&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Raw materials&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - D7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;1,963&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 4 Inventory - D7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium; border-style: none; border-color: currentcolor; width: 1%;" title="FN 4 Inventory - E7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor; width: 9%;"&gt;1,978&lt;/td&gt;&lt;td style="text-align: left; border-width: medium; border-style: none; border-color: currentcolor; width: 1%;" title="FN 4 Inventory - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Reserve for obsolescence&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - D8"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(516&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - D8"&gt;)&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E8"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;(516&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E8"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Inventories, net&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - D9"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;4,645&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 4 Inventory - D9"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E9"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;4,971&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 4 Inventory - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods contextRef="c2" decimals="-3" id="ixv-5546" unitRef="usd">3198000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="c3" decimals="-3" id="ixv-5547" unitRef="usd">3509000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterials contextRef="c2" decimals="-3" id="ixv-5548" unitRef="usd">1963000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="c3" decimals="-3" id="ixv-5549" unitRef="usd">1978000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryValuationReserves contextRef="c2" decimals="-3" id="ixv-5550" unitRef="usd">516000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="c3" decimals="-3" id="ixv-5551" unitRef="usd">516000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet contextRef="c2" decimals="-3" id="ixv-5552" unitRef="usd">4645000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c3" decimals="-3" id="ixv-5553" unitRef="usd">4971000</us-gaap:InventoryNet>
    <wrap:InventoryReserveExpenses contextRef="c0" decimals="-3" id="ixv-5554" unitRef="usd">0</wrap:InventoryReserveExpenses>
    <wrap:InventoryReserveExpenses contextRef="c12" decimals="-3" id="ixv-5555" unitRef="usd">18000</wrap:InventoryReserveExpenses>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c0" id="ixv-2876">&lt;div&gt;
    &lt;p id="xdx_80D_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zhgPYS5SIbyg" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;5. &lt;span id="xdx_82D_zKdcgkAot0Tl"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_898_eus-gaap--PropertyPlantAndEquipmentTextBlock_zDwaQBa2sro5" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Property and equipment consisted of the following:&lt;/p&gt;



    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span id="xdx_8B0_zOGAAWwAEW32" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - C4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold; width: 9%;"&gt;March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - C4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - J4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;December 31, 2025&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - C5"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J5"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Production and lab equipment&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-spacing: 0px;" title="FN 5 Property and Equipment, Net - C6"&gt;$&lt;/td&gt;&lt;td style="text-align : right; width : 9%; ; border-spacing: 0px;"&gt;391&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-spacing: 0px;" title="FN 5 Property and Equipment, Net - C6"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium; border-style: none; border-color: currentcolor; width: 1%;" title="FN 5 Property and Equipment, Net - J6"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor; width: 9%;"&gt;391&lt;/td&gt;&lt;td style="text-align: left; border-width: medium; border-style: none; border-color: currentcolor; width: 1%;" title="FN 5 Property and Equipment, Net - J6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Tooling&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;570&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;570&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Computer equipment&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;188&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;183&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Furniture, fixtures and improvements&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;81&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;81&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Property and equipment, gross&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 5 Property and Equipment, Net - I7"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-spacing: 0px;"&gt;1,230&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;1,225&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;(1,125)&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;(1,102)&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Property and equipment, net&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: left;" title="FN 5 Property and Equipment, Net - I7"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;105&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - J7"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;123&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p id="xdx_8AC_zenEPHVzSCW9" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Depreciation expense was $23 and $40 for the three months ended March 31, 2026 and 2025, respectively.&lt;/p&gt;

    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0" id="ixv-2882">&lt;p id="xdx_898_eus-gaap--PropertyPlantAndEquipmentTextBlock_zDwaQBa2sro5" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Property and equipment consisted of the following:&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - C4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold; width: 9%;"&gt;March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - C4"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - J4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;December 31, 2025&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - C5"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J5"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Production and lab equipment&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-spacing: 0px;" title="FN 5 Property and Equipment, Net - C6"&gt;$&lt;/td&gt;&lt;td style="text-align : right; width : 9%; ; border-spacing: 0px;"&gt;391&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-spacing: 0px;" title="FN 5 Property and Equipment, Net - C6"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium; border-style: none; border-color: currentcolor; width: 1%;" title="FN 5 Property and Equipment, Net - J6"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor; width: 9%;"&gt;391&lt;/td&gt;&lt;td style="text-align: left; border-width: medium; border-style: none; border-color: currentcolor; width: 1%;" title="FN 5 Property and Equipment, Net - J6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Tooling&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;570&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;570&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Computer equipment&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;188&lt;/td&gt;&lt;td style="width: 1%;" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;183&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Furniture, fixtures and improvements&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;81&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;81&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Property and equipment, gross&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 5 Property and Equipment, Net - I7"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; border-spacing: 0px;"&gt;1,230&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%;"&gt;1,225&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;(1,125)&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;(1,102)&lt;/td&gt;&lt;td style="text-align: right; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Property and equipment, net&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: left;" title="FN 5 Property and Equipment, Net - I7"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;105&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - I7"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 5 Property and Equipment, Net - J7"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;123&lt;/td&gt;&lt;td style="text-align: left; width: 1%;" title="FN 5 Property and Equipment, Net - J7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c65" decimals="-3" id="ixv-5556" unitRef="usd">391000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c66" decimals="-3" id="ixv-5557" unitRef="usd">391000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c67" decimals="-3" id="ixv-5558" unitRef="usd">570000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c68" decimals="-3" id="ixv-5559" unitRef="usd">570000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c69" decimals="-3" id="ixv-5560" unitRef="usd">188000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c70" decimals="-3" id="ixv-5561" unitRef="usd">183000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c71" decimals="-3" id="ixv-5562" unitRef="usd">81000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c72" decimals="-3" id="ixv-5563" unitRef="usd">81000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c2" decimals="-3" id="ixv-5564" unitRef="usd">1230000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c3" decimals="-3" id="ixv-5565" unitRef="usd">1225000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c2" decimals="-3" id="ixv-5566" unitRef="usd">1125000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c3" decimals="-3" id="ixv-5567" unitRef="usd">1102000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="-3" id="ixv-5568" unitRef="usd">105000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-3" id="ixv-5569" unitRef="usd">123000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c0" decimals="-3" id="ixv-5570" unitRef="usd">23000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c12" decimals="-3" id="ixv-5571" unitRef="usd">40000</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c0" id="ixv-2991">&lt;div&gt;

    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt; &lt;/p&gt;
    &lt;p id="xdx_80F_eus-gaap--IntangibleAssetsDisclosureTextBlock_zTfd89AZUF5a" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;6. &lt;span id="xdx_824_zuXT4qwqCOqf"&gt;INTANGIBLE ASSETS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;Intangible Assets, net&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_89B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zLRFVhHobhP7" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Intangible assets, net consisted of the following:&lt;/p&gt;



    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center; width: 9%;"&gt;March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Amortizable intangible assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 6 Intangible Rollforward - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 6 Intangible Rollforward - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 6 Intangible Rollforward - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 6 Intangible Rollforward - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,182&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,142&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Trademarks&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;380&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;367&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Purchased software and technology&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;512&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;512&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Gross amortizable intangibles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2,074&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2,021&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Accumulated amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(903&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C11"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(870&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E11"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Total amortizable, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,171&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,151&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Indefinite life assets (non-amortizable)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;421&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;421&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E13"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Total intangible assets, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;1,592&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;1,572&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E14"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p id="xdx_8AC_zyzxSRZHW0Ob" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Amortization expense was $33&lt;span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20250401__20250630_zAfUDrPyl2h1" title="Amortization of Intangible"&gt;&lt;/span&gt; and $115&lt;span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20250101__20250630_zdO8IlWw5ZHh" title="Amortization of Intangible"&gt;&lt;/span&gt; for the three months ended March 31, 2026 and 2025&#160;respectively.&#160;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;
    &lt;p id="xdx_89E_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_z9sdgcbr2gTd" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;As of March 31, 2026, future amortization expense is as follows:&lt;/p&gt;


    &lt;/div&gt;&lt;div&gt;
    &lt;p id="xdx_8A4_zU9qbSEOw7Lk" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2026 (9 months)&lt;/td&gt;&lt;td style="text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C19"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;88&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C19"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;2027&lt;/td&gt;&lt;td style="text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C20"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;116&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C20"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2028&lt;/td&gt;&lt;td style="text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C21"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;116&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C21"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;2029&lt;/td&gt;&lt;td style="text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C22"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;116&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C22"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2030&lt;/td&gt;&lt;td style="text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C23"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;116&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C23"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Thereafter&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 6 Intangible Rollforward - C24"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;"&gt;619&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 6 Intangible Rollforward - C24"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 6 Intangible Rollforward - C25"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;"&gt;1,171&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 6 Intangible Rollforward - C25"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c0" id="ixv-3001">&lt;p id="xdx_89B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zLRFVhHobhP7" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Intangible assets, net consisted of the following:&lt;/p&gt;



    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center; width: 9%;"&gt;March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Amortizable intangible assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 6 Intangible Rollforward - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 6 Intangible Rollforward - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 6 Intangible Rollforward - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 6 Intangible Rollforward - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,182&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,142&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Trademarks&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;380&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;367&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Purchased software and technology&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;512&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;512&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Gross amortizable intangibles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2,074&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2,021&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Accumulated amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(903&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C11"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(870&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E11"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Total amortizable, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,171&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,151&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 6 Intangible Rollforward - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Indefinite life assets (non-amortizable)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;421&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C13"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;421&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E13"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Total intangible assets, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;1,592&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - C14"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E14"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;1,572&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 6 Intangible Rollforward - E14"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c73" decimals="-3" id="ixv-5572" unitRef="usd">1182000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c74" decimals="-3" id="ixv-5573" unitRef="usd">1142000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c75" decimals="-3" id="ixv-5574" unitRef="usd">380000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c76" decimals="-3" id="ixv-5575" unitRef="usd">367000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c77" decimals="-3" id="ixv-5576" unitRef="usd">512000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c78" decimals="-3" id="ixv-5577" unitRef="usd">512000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c2" decimals="-3" id="ixv-5578" unitRef="usd">2074000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c3" decimals="-3" id="ixv-5579" unitRef="usd">2021000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c2" decimals="-3" id="ixv-5580" unitRef="usd">903000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c3" decimals="-3" id="ixv-5581" unitRef="usd">870000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c2" decimals="-3" id="ixv-5582" unitRef="usd">1171000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c3" decimals="-3" id="ixv-5583" unitRef="usd">1151000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c2" decimals="-3" id="ixv-5584" unitRef="usd">421000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c3" decimals="-3" id="ixv-5585" unitRef="usd">421000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c2" decimals="-3" id="ixv-5586" unitRef="usd">1592000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c3" decimals="-3" id="ixv-5587" unitRef="usd">1572000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c0" decimals="-3" id="ixv-5588" unitRef="usd">33000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c12" decimals="-3" id="ixv-5589" unitRef="usd">115000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c0" id="ixv-3125">&lt;div&gt;
    &lt;p id="xdx_89E_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_z9sdgcbr2gTd" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;As of March 31, 2026, future amortization expense is as follows:&lt;/p&gt;


    &lt;/div&gt;&lt;div&gt;
    &lt;p id="xdx_8A4_zU9qbSEOw7Lk" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2026 (9 months)&lt;/td&gt;&lt;td style="text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C19"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;88&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C19"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;2027&lt;/td&gt;&lt;td style="text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C20"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;116&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C20"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2028&lt;/td&gt;&lt;td style="text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C21"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;116&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C21"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;2029&lt;/td&gt;&lt;td style="text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C22"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;116&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C22"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2030&lt;/td&gt;&lt;td style="text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C23"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: initial; border-style: none; border-color: initial;"&gt;116&lt;/td&gt;&lt;td style="text-align: left; border-width: initial; border-style: none; border-color: initial; width: 1%;" title="FN 6 Intangible Rollforward - C23"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Thereafter&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 6 Intangible Rollforward - C24"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 1px solid rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;"&gt;619&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 6 Intangible Rollforward - C24"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total&lt;/td&gt;&lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 6 Intangible Rollforward - C25"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-bottom: 3px double rgb(0, 0, 0); border-top: none; border-left: none; border-right: none;"&gt;1,171&lt;/td&gt;&lt;td style="text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN 6 Intangible Rollforward - C25"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="c2" decimals="-3" id="ixv-5590" unitRef="usd">88000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c2" decimals="-3" id="ixv-5591" unitRef="usd">116000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c2" decimals="-3" id="ixv-5592" unitRef="usd">116000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c2" decimals="-3" id="ixv-5593" unitRef="usd">116000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c2" decimals="-3" id="ixv-5594" unitRef="usd">116000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <wrap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour contextRef="c2" decimals="-3" id="ixv-5595" unitRef="usd">619000</wrap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c2" decimals="-3" id="ixv-5596" unitRef="usd">1171000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c0" id="ixv-3181">&lt;div&gt;&lt;p id="xdx_80A_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zBKpFmwWyFf9" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;7. &lt;span id="xdx_82C_zZcXiusnwfl6"&gt;ACCOUNTS PAYABLE AND
          ACCRUED LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_89C_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zB4sb8F3WHQ6" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Accrued liabilities consist of the following:&lt;/p&gt;
    &lt;p id="xdx_89C_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zB4sb8F3WHQ6-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center; width: 9%;"&gt;March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center; width: 9%;"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Patent and legal costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;134&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;111&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Accrued compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;147&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Warranty costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;32&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;30&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Royalty &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;99&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;99&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Accrued purchases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Taxes and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;119&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;159&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;531&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;407&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;


    &lt;p id="xdx_8AA_z3biZYskGHw1" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p id="xdx_891_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zsYADeXySEVl" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Changes in our estimated product warranty costs were as follows:&lt;/p&gt;



    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Three Months Ended March 31,&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C17"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C17"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E17"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E17"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - C18"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - C18"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - E18"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - E18"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Balance, beginning of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C19"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;30&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C19"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E19"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;83&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E19"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Warranty settlements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C20"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C20"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E20"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(7&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E20"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Warranty provision&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C21"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C21"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E21"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E21"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Balance, end of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C22"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;32&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C22"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E22"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;78&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E22"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span id="xdx_8B3_zrytWJQdisca" style="display: none"&gt;SCHEDULE OF PRODUCT WARRANTY LIABILITY&lt;/span&gt;
      &#160;&lt;/p&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c0" id="ixv-3187">&lt;p id="xdx_89C_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zB4sb8F3WHQ6" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Accrued liabilities consist of the following:&lt;/p&gt;
    &lt;p id="xdx_89C_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zB4sb8F3WHQ6-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center; width: 9%;"&gt;March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C4"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center; width: 9%;"&gt;December 31, 2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Patent and legal costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;134&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;111&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Accrued compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;147&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Warranty costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;32&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;30&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Royalty &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;99&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C9"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E9"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;99&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E9"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Accrued purchases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E10"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Taxes and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;119&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C11"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E11"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;159&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;531&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C12"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E12"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;407&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <wrap:AccruedPatentAndLegalCosts contextRef="c2" decimals="-3" id="ixv-5597" unitRef="usd">134000</wrap:AccruedPatentAndLegalCosts>
    <wrap:AccruedPatentAndLegalCosts contextRef="c3" decimals="-3" id="ixv-5598" unitRef="usd">111000</wrap:AccruedPatentAndLegalCosts>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-5599" unitRef="usd">147000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c3" decimals="-3" id="ixv-5600" unitRef="usd">2000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="c2" decimals="-3" id="ixv-5601" unitRef="usd">32000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="c3" decimals="-3" id="ixv-5602" unitRef="usd">30000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:AccruedRoyaltiesCurrent contextRef="c2" decimals="-3" id="ixv-5603" unitRef="usd">99000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent contextRef="c3" decimals="-3" id="ixv-5604" unitRef="usd">99000</us-gaap:AccruedRoyaltiesCurrent>
    <wrap:AccruedPurchaseCurrent contextRef="c2" decimals="-3" id="ixv-5605" unitRef="usd">0</wrap:AccruedPurchaseCurrent>
    <wrap:AccruedPurchaseCurrent contextRef="c3" decimals="-3" id="ixv-5606" unitRef="usd">6000</wrap:AccruedPurchaseCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-5607" unitRef="usd">119000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c3" decimals="-3" id="ixv-5608" unitRef="usd">159000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-5609" unitRef="usd">531000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c3" decimals="-3" id="ixv-5610" unitRef="usd">407000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="c0" id="ixv-3292">&lt;p id="xdx_891_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zsYADeXySEVl" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Changes in our estimated product warranty costs were as follows:&lt;/p&gt;



    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Three Months Ended March 31,&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C17"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold; width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C17"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E17"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold; width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E17"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - C18"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - C18"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - E18"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 7 Accounts Payable and Accrued Liabilities - E18"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Balance, beginning of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C19"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;30&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C19"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E19"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;83&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E19"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Warranty settlements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C20"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(2&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - C20"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E20"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;(7&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 7 Accounts Payable and Accrued Liabilities - E20"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Warranty provision&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C21"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;4&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C21"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E21"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E21"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Balance, end of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C22"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;32&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - C22"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E22"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;78&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 7 Accounts Payable and Accrued Liabilities - E22"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual contextRef="c3" decimals="-3" id="ixv-5611" unitRef="usd">30000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual contextRef="c33" decimals="-3" id="ixv-5612" unitRef="usd">83000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualPayments contextRef="c0" decimals="-3" id="ixv-5613" unitRef="usd">2000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments contextRef="c12" decimals="-3" id="ixv-5614" unitRef="usd">7000</us-gaap:ProductWarrantyAccrualPayments>
    <wrap:ProductWarrantyExpenseIncome contextRef="c0" decimals="-3" id="ixv-5615" unitRef="usd">4000</wrap:ProductWarrantyExpenseIncome>
    <wrap:ProductWarrantyExpenseIncome contextRef="c12" decimals="-3" id="ixv-5616" unitRef="usd">2000</wrap:ProductWarrantyExpenseIncome>
    <us-gaap:ProductWarrantyAccrual contextRef="c2" decimals="-3" id="ixv-5617" unitRef="usd">32000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual contextRef="c44" decimals="-3" id="ixv-5618" unitRef="usd">78000</us-gaap:ProductWarrantyAccrual>
    <wrap:WarrantsTextBlock contextRef="c0" id="ixv-3372">&lt;div&gt;

    &lt;p id="xdx_80F_ecustom--WarrantsTextBlock_zBHPmjEyGt28" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;b&gt;8. &lt;span id="xdx_820_zXFhFI4K2Bma"&gt;WARRANTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;All outstanding warrants are classified within permanent equity as of March 31, 2026 and December 31, 2025. &lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The following summarizes the Company's outstanding warrants:
&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;i&gt;Series A Warrants&lt;/i&gt; &#x2014; On June 29, 2023, the Company issued warrants (the "Series A Warrants") to purchase up to 6,896,553 shares of Common Stock at an exercise price of $1.45 per share in connection with the Series A Preferred Stock offering. On June 30, 2025, the Company entered into an amendment agreement (the "Series A Warrant Amendment") with the Required Holders (as defined in the Series A Warrants), which resulted in reclassification of the Series A Warrants from warrant liabilities to additional paid-in capital under ASC 815-40. The amended warrants expire on January 3, 2030 (&lt;span style="-sec-ix-hidden: hidden-fact-4"&gt;six and one-half years&lt;/span&gt; from original issuance).
&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;i&gt;PIPE Warrants&lt;/i&gt; &#x2014; On February 24, 2025, the Company issued warrants (the "PIPE Warrants") to purchase up to 3,216,666 shares of Common Stock at an exercise price of $1.80 per share in connection with a private placement. On June 30, 2025, the Company entered into an amendment agreement (the "2025 Warrant Amendment") with the PIPE holders, resulting in reclassification from warrant liabilities to additional paid-in capital under ASC 815-40. The amended PIPE Warrants expire &lt;span style="-sec-ix-hidden: hidden-fact-5"&gt;five and one-half years&lt;/span&gt; from the original issuance date.
&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;i&gt;Series B Warrants&lt;/i&gt; &#x2014; On August 18, 2025, the Company issued warrants (the "Series B Warrants") to purchase up to 3,000,000 shares of Common Stock at an exercise price of $1.50 per share in connection with the Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock") private placement. The Series B Warrants became exercisable on December 12, 2025, the date stockholder approval was obtained, and expire on December 12, 2030. The Series B Warrants are classified within permanent equity.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;



    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255);"&gt;&lt;i&gt;February 2026 Warrants &lt;span style="font-style: normal; letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"&gt;&#x2014;&lt;/span&gt;&lt;/i&gt;&#160;On February 3, 2026, the Company issued pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 800,000 shares of Common Stock at an exercise price of $0.0001 per share and common warrants (the "February 2026 Common Warrants") to purchase up to 2,500,000 shares of Common Stock at an exercise price of $2.30 per share in connection with a private placement. The Pre-Funded Warrants and the February 2026 Common Warrants were classified as equity within additional paid-in capital under ASC 815-40 upon issuance. The Pre-Funded Warrants expire when exercised in full, and the February 2026 Common Warrants expire on February 3, 2031, five years from the date of issuance.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</wrap:WarrantsTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c79"
      decimals="INF"
      id="ixv-5619"
      unitRef="shares">6896553</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c80"
      decimals="INF"
      id="ixv-5620"
      unitRef="usdPershares">1.45</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate contextRef="c81" id="ixv-5621">2030-01-03</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c82"
      decimals="INF"
      id="ixv-5622"
      unitRef="shares">3216666</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c83"
      decimals="INF"
      id="ixv-5623"
      unitRef="usdPershares">1.8</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c85"
      decimals="INF"
      id="ixv-5624"
      unitRef="shares">3000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c86"
      decimals="INF"
      id="ixv-5625"
      unitRef="usdPershares">1.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c86"
      decimals="INF"
      id="ixv-5626"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate contextRef="c87" id="ixv-5627">2030-12-12</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c88"
      decimals="INF"
      id="ixv-5628"
      unitRef="shares">800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c89"
      decimals="INF"
      id="ixv-5629"
      unitRef="usdPershares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c90"
      decimals="INF"
      id="ixv-5630"
      unitRef="shares">2500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c91"
      decimals="INF"
      id="ixv-5631"
      unitRef="usdPershares">2.3</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c92" id="ixv-5632">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0" id="ixv-3405">&lt;div&gt;
    &lt;p id="xdx_80E_eus-gaap--LesseeOperatingLeasesTextBlock_z9ZzlBuT1Bk6" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;9. &lt;span id="xdx_82E_zTvE6DD3mySk"&gt;LEASES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company determines if an arrangement is a lease at inception. The guidance in FASB ASC Topic 842, Leases defines a lease as a contract, or part of a
      contract, that conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration. Operating lease right of use (&#x201c;ROU&#x201d;) assets and lease liabilities are recognized
      based on the present value of future minimum lease payments over the lease term at commencement date. The Company&#x2019;s leases do not provide an implicit rate. Due to a lack of financing history or ability, the Company uses an estimate of low-grade debt
      rate published by the Federal Reserve Bank as its incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The ROU asset includes any lease payments made and excludes
      lease incentives and initial direct costs incurred.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;


    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Amortization expense was $54 and $74 for the three months ended March 31, 2026 and 2025 respectively. Operating lease expense for capitalized operating leases included in operating activities was $112 and $156 for the three months ended March 31, 2026 and 2025, respectively.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_89F_ecustom--LesseeOperatingLeaseDisclosureTableTextBlock_zqRLSAAb8ma5" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Operating lease obligations recorded on the balance sheet at March 31, 2026 are:&lt;/p&gt;
    &lt;p id="xdx_89F_ecustom--LesseeOperatingLeaseDisclosureTableTextBlock_zqRLSAAb8ma5-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p id="xdx_89F_ecustom--LesseeOperatingLeaseDisclosureTableTextBlock_zqRLSAAb8ma5-1" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center; width: 9%;"&gt;March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 9 Lease Reconciliation with life - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 9 Lease Reconciliation with life - C5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Operating lease liability &#x2014; short term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;90&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Operating lease liability &#x2014; long term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;369&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total operating lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;459&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;span id="xdx_8B8_zsredrK4Lttl" style="display: none"&gt;SCHEDULE OF OPERATING LEASE OBLIGATIONS&lt;/span&gt;&#160;&lt;/p&gt;



    &lt;p id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zn2DEV9Gp6vi" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Future lease payments included in the measurement of lease liabilities on the balance sheet at March 31, 2026 for future periods are as follows:&lt;/p&gt;


    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2026 (9 months)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;90&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;120&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2028&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;120&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C13"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;2029&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C14"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;120&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C14"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2030&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C15"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;90&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C15"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Thereafter&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C16"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C16"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total future minimum lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C17"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;540&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C17"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Less imputed interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C18"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(81&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C18"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C19"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;459&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C19"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p id="xdx_8AD_zNrL2X5DtjEf" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The weighted average remaining lease term is &lt;span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zYg38xPGnKbf" title="Operating lease, weighted average remaining lease term"&gt;4.5&lt;/span&gt;&#160;years, and the weighted average discount rate is &lt;span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20250630_z7orZm2zTRZ6" title="Operating lease, weighted average discount rate, percent"&gt;7.5&lt;/span&gt;%&lt;b&gt;.&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Certain leases contain provisions for payment of real estate taxes, insurance and maintenance costs by the Company. These expenses are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred. The Company had $0&#160;and $23&#160;variable lease expenses for the three months ended March 31, 2026 and 2025, respectively.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company had no&#160;short-term lease expenses for the three months ended March 31, 2026 and 2025 respectively. The Company does not have any finance leases.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;On February 13, 2026, the Company entered into a Termination and Mutual Release Agreement with  the landlord of the Company's office space located at 3480 Main Highway, Suite 202, Miami, Florida 33133. Pursuant to the agreement, the office lease dated September 20, 2023 was terminated effective as of February 13, 2026, and the Company surrendered possession of the premises. The landlord agreed to refund the prorated portion of February 2026 rent attributable to the period following the termination date and to return the security deposit in accordance with the terms of the original lease. The parties exchanged mutual releases of all claims arising out of or relating to the lease, except for obligations expressly set forth in the termination agreement and any obligations that by their terms survive termination. In March 2026, the Company entered into a month-to-month service agreement for a business address located at 3350 Virginia Street, Miami, Florida 33133.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt; &#160;&#160;
    &lt;/p&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c0" decimals="-3" id="ixv-5633" unitRef="usd">54000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c12" decimals="-3" id="ixv-5634" unitRef="usd">74000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseCost contextRef="c0" decimals="-3" id="ixv-5635" unitRef="usd">112000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c12" decimals="-3" id="ixv-5636" unitRef="usd">156000</us-gaap:OperatingLeaseCost>
    <wrap:LesseeOperatingLeaseDisclosureTableTextBlock contextRef="c0" id="ixv-3416">&lt;p id="xdx_89F_ecustom--LesseeOperatingLeaseDisclosureTableTextBlock_zqRLSAAb8ma5" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Operating lease obligations recorded on the balance sheet at March 31, 2026 are:&lt;/p&gt;
    &lt;p id="xdx_89F_ecustom--LesseeOperatingLeaseDisclosureTableTextBlock_zqRLSAAb8ma5-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p id="xdx_89F_ecustom--LesseeOperatingLeaseDisclosureTableTextBlock_zqRLSAAb8ma5-1" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C4"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center; width: 9%;"&gt;March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 9 Lease Reconciliation with life - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 9 Lease Reconciliation with life - C5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Operating lease liability &#x2014; short term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C6"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;90&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Operating lease liability &#x2014; long term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C7"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;369&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total operating lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C8"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;459&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</wrap:LesseeOperatingLeaseDisclosureTableTextBlock>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c2" decimals="-3" id="ixv-5637" unitRef="usd">90000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c2" decimals="-3" id="ixv-5638" unitRef="usd">369000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c2" decimals="-3" id="ixv-5639" unitRef="usd">459000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0" id="ixv-3459">&lt;p id="xdx_890_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zn2DEV9Gp6vi" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Future lease payments included in the measurement of lease liabilities on the balance sheet at March 31, 2026 for future periods are as follows:&lt;/p&gt;


    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2026 (9 months)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C11"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;90&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C11"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C12"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;120&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C12"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2028&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C13"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;120&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C13"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;2029&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C14"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;120&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C14"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;2030&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C15"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;90&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C15"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Thereafter&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C16"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 9 Lease Reconciliation with life - C16"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total future minimum lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C17"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;540&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C17"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Less imputed interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C18"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(81&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C18"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C19"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;459&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 9 Lease Reconciliation with life - C19"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c2" decimals="-3" id="ixv-5640" unitRef="usd">90000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c2" decimals="-3" id="ixv-5641" unitRef="usd">120000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c2" decimals="-3" id="ixv-5642" unitRef="usd">120000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c2" decimals="-3" id="ixv-5643" unitRef="usd">120000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c2" decimals="-3" id="ixv-5644" unitRef="usd">90000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c2" decimals="-3" id="ixv-5645" unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c2" decimals="-3" id="ixv-5646" unitRef="usd">540000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c2" decimals="-3" id="ixv-5647" unitRef="usd">81000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c2" decimals="-3" id="ixv-5648" unitRef="usd">459000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c2" id="ixv-3519">P4Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c2" decimals="3" id="ixv-5649" unitRef="pure">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:VariableLeaseCost contextRef="c0" decimals="-3" id="ixv-5650" unitRef="usd">0</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c12" decimals="-3" id="ixv-5651" unitRef="usd">23000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c0" decimals="-3" id="ixv-5652" unitRef="usd">0</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c12" decimals="-3" id="ixv-5653" unitRef="usd">0</us-gaap:ShortTermLeaseCost>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-3537">&lt;div&gt;

    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt; &lt;/p&gt;
    &lt;p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zIqtcRNg1kO7" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;b&gt;10. &lt;span id="xdx_827_zr8JJlKe54Vb"&gt;STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company's authorized capital consists of 200,000,000 shares of Common Stock and 5,000,000 shares of preferred stock, par value $0.0001 per share, of which 10,000 shares are designated as Series A Convertible Preferred Stock and 4,500 shares are designated as Series B Convertible Preferred Stock.
&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: italic 10pt &amp;quot;Times New Roman&amp;quot;; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-decoration: underline;"&gt;Series A Preferred Stock&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;On July 3, 2023, the Company designated and issued 10,000 shares of Series A Preferred Stock (stated value $1,000 per share) convertible into shares of Common Stock at an initial conversion price of $1.45 per share. As of March 31, 2026 and December 31, 2025, there were 8,107 and 8,207 shares outstanding, respectively. Holders are entitled to dividends of 8% per annum, payable in cash or shares of Common Stock at the Company's election. For the three months ended March 31, 2026 and 2025, the Company paid dividends of $249 and $164, respectively, in shares of Common Stock.
&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;



    &lt;/div&gt;&lt;div&gt;



    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockRedemptionTerms_c20240819__20240819__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zYZXGx1UXpj8-1" title="Preferred stock, redemption price description"&gt; &lt;/span&gt; &lt;/p&gt;





    &lt;/div&gt;&lt;div&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;On August 18, 2025, the Company issued 4,500 shares of Series B Preferred Stock (stated value $1,000 per share) convertible up to 3,000,000 shares of Common Stock at an initial conversion price of $1.50 per share. As of March 31, 2026 and December 31, 2025, there were 3,600 and 4,500 shares outstanding, respectively. Holders are entitled to dividends when and as declared by the Board, payable in cash or shares of the Company's securities.&lt;span style="background-color: rgb(255, 255, 255);"&gt; No dividends were declared or paid during the three months ended March 31, 2026.
&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c2"
      decimals="INF"
      id="ixv-5654"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c2"
      decimals="INF"
      id="ixv-5655"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c2"
      decimals="INF"
      id="ixv-5656"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c93"
      decimals="INF"
      id="ixv-5657"
      unitRef="shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c94"
      decimals="INF"
      id="ixv-5658"
      unitRef="shares">4500</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c95"
      decimals="INF"
      id="ixv-5659"
      unitRef="shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <wrap:StockIssuedDuringPeriodSharesSeriesAConvertiblePreferredStock
      contextRef="c96"
      decimals="INF"
      id="ixv-5660"
      unitRef="shares">10000</wrap:StockIssuedDuringPeriodSharesSeriesAConvertiblePreferredStock>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c95"
      decimals="INF"
      id="ixv-5661"
      unitRef="usdPershares">1000</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="c95"
      decimals="INF"
      id="ixv-5662"
      unitRef="usdPershares">1.45</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c93"
      decimals="INF"
      id="ixv-5663"
      unitRef="shares">8107</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c97"
      decimals="INF"
      id="ixv-5664"
      unitRef="shares">8207</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="c96"
      decimals="INF"
      id="ixv-5665"
      unitRef="pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:Dividends contextRef="c98" decimals="-3" id="ixv-5666" unitRef="usd">249000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c99" decimals="-3" id="ixv-5667" unitRef="usd">164000</us-gaap:Dividends>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c100"
      decimals="INF"
      id="ixv-5668"
      unitRef="shares">4500</us-gaap:PreferredStockSharesAuthorized>
    <wrap:StockIssuedDuringPeriodSharesSeriesBConvertiblePreferredStock
      contextRef="c101"
      decimals="INF"
      id="ixv-5669"
      unitRef="shares">4500</wrap:StockIssuedDuringPeriodSharesSeriesBConvertiblePreferredStock>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c100"
      decimals="INF"
      id="ixv-5670"
      unitRef="usdPershares">1000</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="c102"
      decimals="INF"
      id="ixv-5671"
      unitRef="shares">3000000</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="c100"
      decimals="INF"
      id="ixv-5672"
      unitRef="usdPershares">1.5</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c94"
      decimals="INF"
      id="ixv-5673"
      unitRef="shares">3600</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c103"
      decimals="INF"
      id="ixv-5674"
      unitRef="shares">4500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:Dividends contextRef="c104" decimals="-3" id="ixv-5675" unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0" id="ixv-3562">&lt;div&gt;
    &lt;p id="xdx_808_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zz2cii5QLn5a" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;11. &lt;span id="xdx_825_z6m0XaeclZqe"&gt;SHARE-BASED
          COMPENSATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;



    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company maintains the Wrap Technologies, Inc. 2017 Equity Incentive Plan (the "2017 Plan"), which was most recently amended on December 12, 2025 to authorize up to 20,500,000 shares of Common Stock for issuance as equity awards under the 2017 Plan.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt; &lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt; &lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;As of March 31, 2026, there were 4,033,073 shares of Common Stock remaining available for grant under the 2017 Plan.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span style="text-decoration: underline"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zQKS9NuvgsVk" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The following table summarizes stock option activity for the three months ended March 31, 2026:&lt;/p&gt;
    &lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zQKS9NuvgsVk-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C4"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="4" style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Weighted Average &lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN11 Share-Based Compensation - E4"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - I4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Options on
Common
Shares&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="New N11 - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Exercise Price&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="New N11 - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Remaining
Contractual
Terms&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="New N11 - G5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Aggregate
Intrinsic
Value&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="New N11 - I5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - G6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - I6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Outstanding December 31, 2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6,449,534&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C7"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.05&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E7"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;8.56&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G7"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;3,706&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I7"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Granted&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;4,197,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C8"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.21&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E8"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G8"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I8"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Exercised&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C9"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E9"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G9"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I9"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Forfeited, cancelled, expired&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(300,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C10"&gt;)&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.45&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E10"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G10"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I10"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Outstanding March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;10,347,034&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C11"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.10&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E11"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;8.75&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G11"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;402&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I11"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Exercisable March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;3,072,524&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C12"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.31&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E12"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;7.79&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G12"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;141&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I12"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zQKS9NuvgsVk-1" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;


    &lt;/div&gt;&lt;div&gt;
    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;As of March 31, 2026 there were 8,981,868 service-based stock options outstanding, and &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20250630__us-gaap--AwardTypeAxis__custom--PerformanceBasedOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandSeventeenStockIncentivePlanMember_zoD6nF4hS9hb" title="Number of stock options"&gt;1,365,166&lt;/span&gt; performance-based stock options outstanding. For the performance-based options, 1,290,166 were granted in October 2023 to the Company's current Chief Executive Officer, subject to vesting based on future market capitalization targets, and 75,000 were granted to a consultant, subject to vesting upon the Company's execution of a specified customer contract.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_89C_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zoa74hkT8rkk" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company uses the Black-Scholes option pricing model to determine the fair value of the service-based options that have been granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees:&lt;/p&gt;



    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span id="xdx_8B2_zmFsQMJ3Zfhc" style="display: none"&gt;SCHEDULE OF STOCK OPTION ACTIVITY, FAIR VALUE OF ASSUMPTIONS&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Three Months Ended March 31,&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C17"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C17"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E17"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E17"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C18"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C18"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E18"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E18"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Expected stock price volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C19"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;76&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C19"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E19"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;76&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E19"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C20"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;3.87&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C20"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E20"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;4.28&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E20"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C21"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C21"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E21"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E21"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Expected life of options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C22"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C22"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E22"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E22"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Weighted-average fair value of options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C23"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1.55&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C23"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E23"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1.47&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E23"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p id="xdx_8A8_zHpBN7ai0JF6" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Estimated volatility is a measure of the amount by which the Company&#x2019;s stock price is expected to fluctuate each year during the expected life of awards.
      The Company&#x2019;s estimated volatility was based on an average of the historical volatility of peer entities whose stock prices were publicly available. The Company&#x2019;s calculation of estimated volatility is based on the historical stock prices of these
      peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price. The Company records forfeitures as they are incurred.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options. The dividend yield of 0%&#160;is based on the fact that the Company has never paid cash dividends and has no present intention of paying cash dividends. The Company calculates the expected life of the options using the Simplified Method for the employee stock options as the Company does not have sufficient historical exercise data.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Stock option expense was $2,033 and $387 for the three months ended March 31, 2026 and 2025, respectively. &lt;/p&gt;


    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt; &lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span style="text-decoration: underline"&gt;Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_89C_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_zwq1l13Jxyef" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The 2017 Plan provides for the grant of restricted stock units (&#x201c;RSUs&#x201d;). RSUs are settled in shares of the Company&#x2019;s Common Stock as the RSUs vest. The following table summarizes RSU activity for the three months ended March 31, 2026:&lt;/p&gt;



    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C28"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C28"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Weighted Average&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C29"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Service-Based
RSUs&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C29"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E29"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Grant Date
Fair Value&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E29"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - G29"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Vesting
Period
(Years)&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - G29"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C30"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C30"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E30"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E30"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - G30"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - G30"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Unvested at December 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C31"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,014,563&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C31"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E31"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.23&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E31"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G31"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;3.62&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G31"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Granted service based&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C32"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;81,052&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C32"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E32"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.46&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E32"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G32"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G32"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;" title="New N11 - C33"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;"&gt;(72,888&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;" title="New N11 - C33"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E33"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.26&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E33"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G33"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G33"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Forfeited and cancelled&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" title="New N11 - C34"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C34"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E34"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E34"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" title="New N11 - G34"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" title="New N11 - G34"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Unvested at March 31, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;" title="New N11 - C35"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;"&gt;1,022,727&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;" title="New N11 - C35"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E35"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E35"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" title="New N11 - G35"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;3.69&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" title="New N11 - G35"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span id="xdx_8B7_zlICt5T0wdJ2" style="display: none"&gt;SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY&lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company used the Monte Carlo Simulation Model to value at the grant date the aggregate of &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20240101__20240131__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWVzk82yGqgc" title="Restricted stock units, granted"&gt;632,911&lt;/span&gt; market condition performance RSUs granted in January 2024 to the Company&#x2019;s Chief Executive Officer. The assumptions used in the Monte Carlo Simulation were stock price on the date of grant equal to $&lt;span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5SEzm2kQYT4" title="Stock price"&gt;3.40&lt;/span&gt;, a contract term of &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zsqF91PeAw0e" title="Contract term"&gt;10&lt;/span&gt; years, expected volatility of &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3ghMbQNJTp2" title="Expected volatility"&gt;78&lt;/span&gt;% and risk-free interest rate of &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zaw20qoz2Rwk" title="Risk-free interest rate"&gt;4.10&lt;/span&gt;%. Vesting is based on sustained market capitalization of $&lt;span id="xdx_906_ecustom--MarketCapital_iI_pn9n9_c20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgIMg1YItXQ8" title="Market capital"&gt;1&lt;/span&gt; billion, and the derived service period is &lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_dtY_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zbiWexZHXWl7" title="Service period"&gt;4.3&lt;/span&gt; years.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;RSU expense was $351 and $1,278 for the three months ended March 31, 2026 and 2025, respectively. &lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span style="text-decoration: underline"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p id="xdx_89D_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zLdpUzSeoP56" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company recorded share-based compensation for options and RSUs in its statements of operations for the relevant periods as follows:&lt;/p&gt;
    &lt;p id="xdx_89D_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zLdpUzSeoP56-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Three Months Ended March 31,&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C40"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C40"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E40"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E40"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C41"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C41"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E41"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E41"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Selling, general and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C42"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2,384&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C42"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E42"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,603&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E42"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C43"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C43"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E43"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;62&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E43"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total share-based expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C44"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2,384&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C44"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E44"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;1,665&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E44"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;span id="xdx_8BC_zyaVeOEOBwu4" style="display: none"&gt;SCHEDULE OF SHARE-BASED COMPENSATION FOR OPTIONS AND RESTRICTED STOCK UNITS&lt;/span&gt;&lt;/p&gt;


    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;As of March 31, 2026, total estimated compensation cost of stock options granted and outstanding but not yet vested was $8,707 which is expected to be recognized over the weighted average period of 2.94 years.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;As of March 31, 2026, total estimated compensation cost of RSUs granted and outstanding but not yet vested was $&lt;span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zbusYqrmhGkb" title="Unrecognized stock-based         compensation"&gt;1,004&lt;/span&gt;, which is expected to be recognized over the weighted average period of 1.88&lt;span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20250101__20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJ2zOZKvPuK6" title="Weighted average period"&gt;&lt;/span&gt;&#160;years.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c105"
      decimals="INF"
      id="ixv-5676"
      unitRef="shares">20500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c106"
      decimals="INF"
      id="ixv-5677"
      unitRef="shares">4033073</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0" id="ixv-3578">&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zQKS9NuvgsVk" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The following table summarizes stock option activity for the three months ended March 31, 2026:&lt;/p&gt;
    &lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zQKS9NuvgsVk-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C4"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="4" style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Weighted Average &lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="FN11 Share-Based Compensation - E4"&gt;&#160;&lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - I4"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Options on
Common
Shares&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="New N11 - C5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Exercise Price&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="New N11 - E5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Remaining
Contractual
Terms&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="New N11 - G5"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;Aggregate
Intrinsic
Value&lt;/td&gt;&lt;td style="border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%;" title="New N11 - I5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - G6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - I6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Outstanding December 31, 2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6,449,534&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C7"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.05&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E7"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;8.56&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G7"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;3,706&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I7"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Granted&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;4,197,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C8"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.21&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E8"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G8"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I8"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Exercised&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C9"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E9"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G9"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I9"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Forfeited, cancelled, expired&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;(300,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C10"&gt;)&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.45&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E10"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G10"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I10"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Outstanding March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;10,347,034&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C11"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.10&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E11"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;8.75&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G11"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;402&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I11"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Exercisable March 31, 2026&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;3,072,524&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C12"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.31&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E12"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;7.79&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G12"&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;141&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - I12"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c3"
      decimals="INF"
      id="ixv-5678"
      unitRef="shares">6449534</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c3"
      decimals="2"
      id="ixv-5679"
      unitRef="usdPershares">2.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c0" id="ixv-5680">P8Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c3" decimals="-3" id="ixv-5681" unitRef="usd">3706000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="c0"
      decimals="INF"
      id="ixv-5682"
      unitRef="shares">4197500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="2"
      id="ixv-5683"
      unitRef="usdPershares">2.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c0"
      decimals="INF"
      id="ixv-5684"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="0"
      id="ixv-5685"
      unitRef="usdPershares">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c0"
      decimals="INF"
      id="ixv-5686"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="2"
      id="ixv-5687"
      unitRef="usdPershares">2.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c2"
      decimals="INF"
      id="ixv-5688"
      unitRef="shares">10347034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c2"
      decimals="2"
      id="ixv-5689"
      unitRef="usdPershares">2.1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <wrap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3 contextRef="c0" id="ixv-5690">P8Y9M</wrap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c2" decimals="-3" id="ixv-5691" unitRef="usd">402000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c2"
      decimals="INF"
      id="ixv-5692"
      unitRef="shares">3072524</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c2"
      decimals="2"
      id="ixv-5693"
      unitRef="usdPershares">2.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c0" id="ixv-5694">P7Y9M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c2" decimals="-3" id="ixv-5695" unitRef="usd">141000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c107"
      decimals="INF"
      id="ixv-5696"
      unitRef="shares">8981868</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c108"
      decimals="INF"
      id="ixv-5697"
      unitRef="shares">1365166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c109"
      decimals="INF"
      id="ixv-5698"
      unitRef="shares">1290166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c110"
      decimals="INF"
      id="ixv-5699"
      unitRef="shares">75000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c0" id="ixv-3744">&lt;p id="xdx_89C_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zoa74hkT8rkk" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company uses the Black-Scholes option pricing model to determine the fair value of the service-based options that have been granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees:&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Three Months Ended March 31,&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C17"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C17"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E17"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E17"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C18"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C18"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E18"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E18"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Expected stock price volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C19"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;76&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C19"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E19"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;76&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E19"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C20"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;3.87&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C20"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E20"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;4.28&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E20"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C21"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C21"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E21"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E21"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Expected life of options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C22"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C22"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E22"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;6&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E22"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Weighted-average fair value of options granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C23"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1.55&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C23"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E23"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1.47&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E23"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c111" decimals="2" id="ixv-5700" unitRef="pure">0.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c112" decimals="2" id="ixv-5701" unitRef="pure">0.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c111" decimals="4" id="ixv-5702" unitRef="pure">0.0387</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c112" decimals="4" id="ixv-5703" unitRef="pure">0.0428</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c111" decimals="2" id="ixv-5704" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c112" decimals="2" id="ixv-5705" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c111" id="ixv-5706">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c112" id="ixv-5707">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c111"
      decimals="2"
      id="ixv-5708"
      unitRef="usdPershares">1.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c112"
      decimals="2"
      id="ixv-5709"
      unitRef="usdPershares">1.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c111" decimals="2" id="ixv-5710" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c111" decimals="-3" id="ixv-5711" unitRef="usd">2033000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c112" decimals="-3" id="ixv-5712" unitRef="usd">387000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="c0" id="ixv-3846">&lt;p id="xdx_89C_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_zwq1l13Jxyef" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The 2017 Plan provides for the grant of restricted stock units (&#x201c;RSUs&#x201d;). RSUs are settled in shares of the Company&#x2019;s Common Stock as the RSUs vest. The following table summarizes RSU activity for the three months ended March 31, 2026:&lt;/p&gt;



    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C28"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C28"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Weighted Average&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C29"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Service-Based
RSUs&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C29"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E29"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Grant Date
Fair Value&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E29"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - G29"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Vesting
Period
(Years)&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - G29"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C30"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C30"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E30"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E30"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - G30"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - G30"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Unvested at December 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C31"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,014,563&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C31"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E31"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.23&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E31"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G31"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;3.62&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G31"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Granted service based&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C32"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;81,052&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C32"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E32"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.46&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E32"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G32"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G32"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;" title="New N11 - C33"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;"&gt;(72,888&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;" title="New N11 - C33"&gt;)&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E33"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2.26&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E33"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G33"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - G33"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Forfeited and cancelled&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" title="New N11 - C34"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C34"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E34"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E34"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" title="New N11 - G34"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" title="New N11 - G34"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Unvested at March 31, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;" title="New N11 - C35"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;"&gt;1,022,727&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; border-image: initial;" title="New N11 - C35"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E35"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E35"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" title="New N11 - G35"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium; border-style: none; border-color: currentcolor;"&gt;3.69&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" title="New N11 - G35"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c118"
      decimals="INF"
      id="ixv-5713"
      unitRef="shares">1014563</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c118"
      decimals="2"
      id="ixv-5714"
      unitRef="usdPershares">2.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c119" id="ixv-5715">P3Y7M13D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c115"
      decimals="INF"
      id="ixv-5716"
      unitRef="shares">81052</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c115"
      decimals="2"
      id="ixv-5717"
      unitRef="usdPershares">2.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c115"
      decimals="INF"
      id="ixv-5718"
      unitRef="shares">72888</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c115"
      decimals="2"
      id="ixv-5719"
      unitRef="usdPershares">2.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c115"
      decimals="INF"
      id="ixv-5720"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c115"
      decimals="0"
      id="ixv-5721"
      unitRef="usdPershares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c114"
      decimals="INF"
      id="ixv-5722"
      unitRef="shares">1022727</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c114"
      decimals="2"
      id="ixv-5723"
      unitRef="usdPershares">2.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <wrap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod2 contextRef="c115" id="ixv-5724">P3Y8M8D</wrap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c113"
      decimals="INF"
      id="ixv-5725"
      unitRef="shares">632911</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharePrice
      contextRef="c114"
      decimals="INF"
      id="ixv-5726"
      unitRef="usdPershares">3.4</us-gaap:SharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c115" id="ixv-3975">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c115"
      decimals="INF"
      id="ixv-5727"
      unitRef="pure">0.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c115"
      decimals="INF"
      id="ixv-5728"
      unitRef="pure">0.041</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <wrap:MarketCapital contextRef="c114" decimals="-9" id="ixv-5729" unitRef="usd">1000000000</wrap:MarketCapital>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 contextRef="c115" id="ixv-3980">P4Y3M18D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c115" decimals="-3" id="ixv-5730" unitRef="usd">351000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c116" decimals="-3" id="ixv-5731" unitRef="usd">1278000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c0" id="ixv-3995">&lt;p id="xdx_89D_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zLdpUzSeoP56" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company recorded share-based compensation for options and RSUs in its statements of operations for the relevant periods as follows:&lt;/p&gt;
    &lt;p id="xdx_89D_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zLdpUzSeoP56-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Three Months Ended March 31,&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C40"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C40"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E40"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; width: 9%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E40"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C41"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - C41"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E41"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="New N11 - E41"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Selling, general and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C42"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;2,384&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - C42"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E42"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;1,603&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="New N11 - E42"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C43"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C43"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E43"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;62&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E43"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total share-based expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C44"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;2,384&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - C44"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E44"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;1,665&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="New N11 - E44"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c120" decimals="-3" id="ixv-5732" unitRef="usd">2384000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c121" decimals="-3" id="ixv-5733" unitRef="usd">1603000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c122" decimals="-3" id="ixv-5734" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c123" decimals="-3" id="ixv-5735" unitRef="usd">62000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c0" decimals="-3" id="ixv-5736" unitRef="usd">2384000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c12" decimals="-3" id="ixv-5737" unitRef="usd">1665000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c117" decimals="-3" id="ixv-5738" unitRef="usd">8707000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c111" id="ixv-5739">P2Y11M8D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c114" decimals="-3" id="ixv-5740" unitRef="usd">1004000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c115" id="ixv-5741">P1Y10M17D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:DefinedContributionPlanTextBlock contextRef="c0" id="ixv-4071">&lt;div&gt;
    &lt;p id="xdx_802_eus-gaap--DefinedContributionPlanTextBlock_zbJLduuLI7W1" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;12. &lt;span id="xdx_82B_z4WSwaEGOQ56"&gt;DEFINED CONTRIBUTION PLAN&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company has a defined contribution savings plan for all eligible U.S. employees established under the provisions of Section 401(k) of the Internal Revenue Code. This plan was formed on January 1, 2022. Eligible employees may contribute a percentage of their salary subject to certain limitations. The Company&#x2019;s matching contributions were $13 and $0 for the three months ended March 31, 2026 and 2025, respectively.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;/div&gt;</us-gaap:DefinedContributionPlanTextBlock>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c0" decimals="-3" id="ixv-5742" unitRef="usd">13000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c12" decimals="-3" id="ixv-5743" unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-4079">&lt;div&gt;

    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt; &lt;/p&gt;
    &lt;p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zSp6Ma869093" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;13. &lt;span id="xdx_82C_zRShBvGxVuzd"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span style="text-decoration: underline"&gt;Purchase Commitments&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;As of March 31, 2026, the Company was committed for approximately $541 for future component deliveries that are generally subject to modification or rescheduling in the normal course of business.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span style="text-decoration: underline"&gt;Indemnifications and Guarantees&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Our officers and directors are indemnified as to personal liability as provided by Delaware law and the Company&#x2019;s certificate of incorporation and bylaws.
      The Company may also undertake indemnification obligations in the ordinary course of business related to its operations. The Company is unable to estimate with any reasonable accuracy the liability that may be incurred pursuant to any such
      indemnification obligations now or in the future. Because of the uncertainty surrounding these circumstances, the Company&#x2019;s current or future indemnification obligations could range from immaterial to having a material adverse impact on its financial
      position and its ability to continue in the ordinary course of business. The Company has no liabilities recorded for such indemnities.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;




    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span style="text-decoration: underline"&gt;Litigation&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company is subject to litigation and other claims in the ordinary course of business. The Company records a provision for a liability relating to
      legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed and adjusted to include the impacts of negotiations, estimated settlements, legal rulings,
      advice of legal counsel, and other information and events pertaining to a particular matter. As of March 31, 2026, the Company had no provision for liability under existing litigation.&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;



    &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ContractualObligation contextRef="c2" decimals="-3" id="ixv-5744" unitRef="usd">541000</us-gaap:ContractualObligation>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0" id="ixv-4106">&lt;div&gt;
    &lt;p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zthdmYfmVT7g" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;14. &lt;span id="xdx_823_z9i1UXXIJW2a"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;i&gt;Series A Preferred Stock&lt;/i&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;Scot Cohen, the Company's Executive Chairman and Chief Executive Officer, holds directly and through V4 Global LLC ("V4"), an entity he controls, shares of Series A Preferred Stock and related warrants. For the three months ended March 31, 2026, Mr. Cohen earned dividends totaling&lt;span style="background-color: rgb(255, 255, 255);"&gt; $91 o&lt;/span&gt;n his Series A Preferred Stock.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;

    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;i&gt;Series B Preferred Stock
&lt;/i&gt;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;
In the private placement of Series B Preferred Stock completed August 18, 2025, V4 purchased 1,000 shares of Series B Preferred Stock and 666,667 Series B Warrants for gross proceeds of $1,000.
&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;i&gt;PIPE Warrants
&lt;/i&gt;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;In the February 2025 private placement, V4 purchased 1,100,000 shares of Common Stock and 1,100,000 PIPE Warrants for gross proceeds of $1,980; Continuum Ventures, LLC (controlled by Jared Novick, President and Chief Operating Officer) purchased 275,000 shares of Common Stock and 275,000 PIPE Warrants for gross proceeds of $495; and Savbo Investments LLC (controlled by Marc Savas, a Board member) purchased 50,000 shares of Common Stock and 50,000 PIPE Warrants for gross proceeds of $90. In the February 2026 private placement, V4
purchased 475,000 shares of Common Stock and 475,000 February 2026 Common
Warrants for gross proceeds of $950; Savbo Investments LLC purchased 25,000
shares of Common Stock and 25,000 February 2026 Common Warrants for gross
proceeds of $50; and Juggernaut Management, LLC (controlled by John Shulman, a
Board member) purchased 250,000 shares of Common Stock and 250,000 February
2026 Common Warrants for gross proceeds of $500.&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;i&gt;License Agreement
&lt;/i&gt;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company is party to a royalty license with Syzygy, a company owned by Elwood G. Norris, a 5% or greater stockholder, and James A. Barnes, a stockholder. &lt;/p&gt;

    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;
    &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:Dividends contextRef="c124" decimals="-3" id="ixv-5745" unitRef="usd">91000</us-gaap:Dividends>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c125"
      decimals="INF"
      id="ixv-5746"
      unitRef="shares">1000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c126"
      decimals="INF"
      id="ixv-5747"
      unitRef="shares">666667</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c126" decimals="-3" id="ixv-5748" unitRef="usd">1000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c127"
      decimals="INF"
      id="ixv-5749"
      unitRef="shares">1100000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c128"
      decimals="INF"
      id="ixv-5750"
      unitRef="shares">1100000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c129" decimals="-3" id="ixv-5751" unitRef="usd">1980000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c130"
      decimals="INF"
      id="ixv-5752"
      unitRef="shares">275000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c131"
      decimals="INF"
      id="ixv-5753"
      unitRef="shares">275000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c132" decimals="-3" id="ixv-5754" unitRef="usd">495000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c133"
      decimals="INF"
      id="ixv-5755"
      unitRef="shares">50000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c134"
      decimals="INF"
      id="ixv-5756"
      unitRef="shares">50000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c135" decimals="-3" id="ixv-5757" unitRef="usd">90000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c136"
      decimals="INF"
      id="ixv-5758"
      unitRef="shares">475000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c137"
      decimals="0"
      id="ixv-5759"
      unitRef="shares">475000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c138" decimals="0" id="ixv-5760" unitRef="usd">950</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c139"
      decimals="INF"
      id="ixv-5761"
      unitRef="shares">25000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c140"
      decimals="INF"
      id="ixv-5762"
      unitRef="shares">25000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c141" decimals="0" id="ixv-5763" unitRef="usd">50</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c142"
      decimals="INF"
      id="ixv-5764"
      unitRef="shares">250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c143"
      decimals="INF"
      id="ixv-5765"
      unitRef="shares">250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c144" decimals="0" id="ixv-5766" unitRef="usd">500</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <wrap:StockholderOwnershipPercentage
      contextRef="c145"
      decimals="INF"
      id="ixv-5767"
      unitRef="pure">0.05</wrap:StockholderOwnershipPercentage>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c0" id="ixv-4134">&lt;div&gt;

    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt; &lt;/p&gt;
    &lt;p id="xdx_80E_eus-gaap--ConcentrationRiskDisclosureTextBlock_z1iApJrr8ya4" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;b&gt;15. &lt;span id="xdx_827_znMAnP8Whfr6"&gt;MAJOR CUSTOMERS AND RELATED INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;

    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;For the three months ended March 31, 2026, revenue from one customer accounted for approximatel&lt;span style="background-color: rgb(255, 255, 255);"&gt;y 40% &lt;/span&gt;of revenue, with no other single customer accounting for more than 10% of total revenue. For the three months ended March 31, 2025, revenue from three customers accounted for approximately 13%, 13% and 11% of revenue, respectively.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;At March 31, 2026, accounts receivable from three distributors accounted for 29%, 24%, and 14% of net accounts receivable and contract assets with no other single customer accounting for more than 10% of the accounts receivable and contract assets balance. At December 31, 2025, accounts receivable from two distributors accounted for 71% and 10%, respectively of net accounts receivable and contract assets, with no other single customer accounting for more than 10% of the accounts receivable and contract assets balance.&lt;/p&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&#160;&lt;/p&gt;




    &lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zZz1oTZikLX7" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The following table summarizes revenue by geographic region. Revenue is attributed to countries based on customer&#x2019;s delivery location:&lt;/p&gt;

    &lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zZz1oTZikLX7-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Three Months Ended March 31,&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C5"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E5"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 15 Revenue by shipped to country - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 15 Revenue by shipped to country - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 15 Revenue by shipped to country - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 15 Revenue by shipped to country - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Americas&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 15 Revenue by shipped to country - C7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;645&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 15 Revenue by shipped to country - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 15 Revenue by shipped to country - E7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;651&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 15 Revenue by shipped to country - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Europe, Middle East and Africa&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;466&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;114&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;1,111&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;765&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;span id="xdx_8BA_zptgPt2cQGr9" style="display: none"&gt;SCHEDULE OF DISAGGREGATION OF REVENUE&lt;/span&gt;&lt;/p&gt;

    &lt;p id="xdx_8AA_z4WZjPjqyYH2" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <wrap:NumberOfMajorCustomers
      contextRef="c146"
      decimals="INF"
      id="ixv-5768"
      unitRef="Customers">1</wrap:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c147" decimals="2" id="ixv-5769" unitRef="pure">0.40</us-gaap:ConcentrationRiskPercentage1>
    <wrap:NumberOfMajorCustomers
      contextRef="c148"
      decimals="INF"
      id="ixv-5770"
      unitRef="Customers">3</wrap:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c149" decimals="2" id="ixv-5771" unitRef="pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c150" decimals="2" id="ixv-5772" unitRef="pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c151" decimals="2" id="ixv-5773" unitRef="pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <wrap:NumberOfMajorDistributors
      contextRef="c152"
      decimals="INF"
      id="ixv-5774"
      unitRef="Distributors">3</wrap:NumberOfMajorDistributors>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c153" decimals="2" id="ixv-5775" unitRef="pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c154" decimals="2" id="ixv-5776" unitRef="pure">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c155" decimals="2" id="ixv-5777" unitRef="pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <wrap:NumberOfMajorDistributors
      contextRef="c156"
      decimals="INF"
      id="ixv-5778"
      unitRef="Distributors">2</wrap:NumberOfMajorDistributors>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c157" decimals="2" id="ixv-5779" unitRef="pure">0.71</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c158" decimals="2" id="ixv-5780" unitRef="pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c0" id="ixv-4146">&lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zZz1oTZikLX7" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The following table summarizes revenue by geographic region. Revenue is attributed to countries based on customer&#x2019;s delivery location:&lt;/p&gt;

    &lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zZz1oTZikLX7-0" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td colspan="7" style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;Three Months Ended March 31,&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C5"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C5"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E5"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 9%;"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E5"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 15 Revenue by shipped to country - C6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 15 Revenue by shipped to country - C6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 15 Revenue by shipped to country - E6"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" title="FN 15 Revenue by shipped to country - E6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Americas&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 15 Revenue by shipped to country - C7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;645&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 15 Revenue by shipped to country - C7"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 15 Revenue by shipped to country - E7"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right;"&gt;651&lt;/td&gt;&lt;td style="width: 1%; text-align: left;" title="FN 15 Revenue by shipped to country - E7"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Europe, Middle East and Africa&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;466&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C8"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E8"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;114&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 1px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="background-color: rgb(204, 238, 255);"&gt;&lt;td&gt;Total revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;1,111&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - C10"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E10"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;765&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-width: medium medium 3px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" title="FN 15 Revenue by shipped to country - E10"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <wrap:RevenuesGross contextRef="c159" decimals="-3" id="ixv-5781" unitRef="usd">645000</wrap:RevenuesGross>
    <wrap:RevenuesGross contextRef="c160" decimals="-3" id="ixv-5782" unitRef="usd">651000</wrap:RevenuesGross>
    <wrap:RevenuesGross contextRef="c161" decimals="-3" id="ixv-5783" unitRef="usd">466000</wrap:RevenuesGross>
    <wrap:RevenuesGross contextRef="c162" decimals="-3" id="ixv-5784" unitRef="usd">114000</wrap:RevenuesGross>
    <wrap:RevenuesGross contextRef="c0" decimals="-3" id="ixv-5785" unitRef="usd">1111000</wrap:RevenuesGross>
    <wrap:RevenuesGross contextRef="c12" decimals="-3" id="ixv-5786" unitRef="usd">765000</wrap:RevenuesGross>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0" id="ixv-4217">&lt;div&gt;
    &lt;p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zKDTImdBX7md" style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&lt;b&gt;16. &lt;span id="xdx_821_zhUbD62Wx2D8"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
    &lt;p style="font: 10pt 'Times New Roman'; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;


    &lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;The Company has reviewed activities through May 13, 2026, the date on which this Quarterly Report on Form 10-Q was filed with the Securities and Exchange Commission, and has determined there are no subsequent events requiring disclosure in accordance with ASC 855-10-25-1.&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; font-variant-emoji: normal; font-stretch: normal; line-height: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"&gt;&#160;&lt;/p&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c0" id="ixv-5787">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c0" id="ixv-5788">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c0" id="ixv-5789">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c0" id="ixv-5790">false</ecd:Rule10b51ArrAdoptedFlag>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c2"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c3"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c0"
      decimals="INF"
      id="hidden-fact-2"
      unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c0"
      decimals="INF"
      id="hidden-fact-3"
      unitRef="Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c81" id="hidden-fact-4">P6Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c84" id="hidden-fact-5">P5Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-5799">0001702924</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-5800">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-5801">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-5802">--12-31</dei:CurrentFiscalYearEndDate>
</xbrl>
